##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.1-753-gd2b1864
##SAMPLE=<ID=NA12878_18,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##DESCRIPTION=NA12878_18=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group (Neoplasms).
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	NA12878_18	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	8022801	8022801	T	-	het		QUAL=545;DP=166;AF=0.25;MQM=60	PARK7	intron	PARK7:ENST00000338639:intron_variant:MODIFIER:exon1/6:c.-23-4del::,PARK7:ENST00000377488:intron_variant:MODIFIER:exon1/6:c.-23-4del::,PARK7:ENST00000377491:intron_variant:MODIFIER:exon1/6:c.-23-4del::,PARK7:ENST00000377493:intron_variant:MODIFIER:exon1/5:c.-23-4del::,PARK7:ENST00000493678:intron_variant:MODIFIER:exon1/6:c.-23-4del::	regulatory_region_variant:promoter	602533 [GENE=PARK7 PHENOS=Parkinson disease 7,autosomal recessive early-onset,606324,Autosomal recessive];			(T)n (Simple_repeat)	rs370370394		0.3604	93,.	0.3528,0.3486,0.3450,0.3586,0.3856	1.1200				2.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARK7 (inh=AR oe_syn=0.93 oe_mis=0.96 oe_lof=0.11)
chr1	17312592	17312592	G	A	het		QUAL=13903;DP=1255;AF=0.51;MQM=60	ATP13A2,RP1-37C10.3	3'UTR,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:ENST00000341676:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+6985G>A::,ATP13A2:ENST00000452699:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293763 [benign DISEASE=Parkinson disease 9];			rs15786	0.0132	0.0467	52,.	0.0092,0.0132,0.0000,0.0598,0.0099	0.4710	 ,D(0.00), , 	 ,B(0.02), , 	0.19,0.82	11.89	0.12					23	775	5 / 54					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17312743	17312743	C	T	hom		QUAL=34940;DP=1158;AF=0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7136C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13	0.48	0.24					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313157	17313157	G	A	hom		QUAL=35253;DP=1247;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon27/28:c.3236-30C>T::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7550G>A::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon27/28:c.3221-30C>T::	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13	5.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313343	17313343	G	A	hom		QUAL=46821;DP=1502;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7736G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19	1.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313654	17313654	C	T	hom		QUAL=35956;DP=1206;AF=0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+8047C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72	13.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17314942	17314942	G	A	hom		QUAL=20708;DP=642;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+9335G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67	14.31			gain/donor/17314941-17314942/Medium/0.871549			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17319011	17319011	G	A	hom		QUAL=41992;DP=1498;AF=0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.188-12127G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95	14.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17323449	17323449	T	C	hom		QUAL=20455;DP=703;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon12/28:c.1195+66A>G::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon12/26:c.1180+66A>G::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.188-7689T>C::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon12/28:c.1180+66A>G::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];			MIR3 (SINE/MIR)	rs9435736		0.8030	10129,.		-0.8220			0.00,0.04	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	43393245	43393245	-	GGTGAGAAAT	het		QUAL=1651;DP=361;AF=0.34;MQM=60	SLC2A1	intron	SLC2A1:ENST00000426263:intron_variant:MODIFIER:exon9/9:c.1278+30_1278+31insATTTCTCACC::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];				rs11282849	0.6174	0.5517	4915,.						3.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	65830298	65830298	T	-	het		QUAL=1188;DP=158;AF=0.34;MQM=60	DNAJC6	intron	DNAJC6:ENST00000263441:intron_variant:MODIFIER:exon2/19:c.-17-6del::,DNAJC6:ENST00000371069:intron_variant:MODIFIER:exon1/18:c.194-6del::,DNAJC6:ENST00000395325:intron_variant:MODIFIER:exon1/18:c.23-6del::		608375 [GENE=DNAJC6 PHENOS=Parkinson disease 19a,juvenile-onset,615528,Autosomal recessive/Parkinson disease 19b,early-onset,615528,Autosomal recessive];			(T)n (Simple_repeat)	rs753190937		0.1238	250,.	0.1352,0.1015,0.1054,0.0342,0.0827	0.2690				0.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAJC6 (inh=AR oe_syn=0.94 oe_mis=0.80 oe_lof=0.11)
chr1	78578177	78578177	T	C	het		QUAL=4362;DP=568;AF=0.34;MQM=60	GIPC2	intron	GIPC2:ENST00000370759:intron_variant:MODIFIER:exon3/5:c.608-6900T>C::						rs6666954	0.4489	0.3754	2617,.	0.6112,0.2545,0.6166,0.2758,0.2698	-1.2050			0.00,0.05	1.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	181003340	181003340	-	G	het		QUAL=919;DP=139;AF=0.38;MQM=60	MR1	intron	MR1:ENST00000282990:intron_variant:MODIFIER:exon1/4:c.67+131dup::,MR1:ENST00000367579:intron_variant:MODIFIER:exon1/5:c.67+131dup::,MR1:ENST00000367580:intron_variant:MODIFIER:exon1/5:c.67+131dup::,MR1:ENST00000434571:intron_variant:MODIFIER:exon1/3:c.67+131dup::	regulatory_region_variant:promoter					rs61482628	0.3207	0.2947	1559,.						5.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181018096	181018096	T	C	het		QUAL=7892;DP=998;AF=0.38;MQM=43	MR1	intron	MR1:ENST00000282990:intron_variant:MODIFIER:exon1/4:c.68-92T>C::,MR1:ENST00000367579:intron_variant:MODIFIER:exon1/5:c.68-92T>C::,MR1:ENST00000367580:intron_variant:MODIFIER:exon1/5:c.68-92T>C::,MR1:ENST00000434571:intron_variant:MODIFIER:exon1/3:c.68-92T>C::						rs2236412	0.0519	0.0654	76,.		-2.0610			0.00,0.07	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181018180	181018180	C	G	het		QUAL=20463;DP=1271;AF=0.60;MQM=60	MR1	splice_region&intron	MR1:ENST00000282990:splice_region_variant&intron_variant:LOW:exon1/4:c.68-8C>G::,MR1:ENST00000367579:splice_region_variant&intron_variant:LOW:exon1/5:c.68-8C>G::,MR1:ENST00000367580:splice_region_variant&intron_variant:LOW:exon1/5:c.68-8C>G::,MR1:ENST00000434571:splice_region_variant&intron_variant:LOW:exon1/3:c.68-8C>G::						rs2236411	0.1058	0.1088	237,.	0.1966,0.0597,0.0709,0.0850,0.0495	0.2130			0.10,0.17	0.33		10.00>9.52		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181018236	181018236	A	G	het		QUAL=15317;DP=1162;AF=0.52;MQM=56	MR1	missense	MR1:ENST00000282990:missense_variant:MODERATE:exon2/5:c.116A>G:p.His39Arg:PF00129,MR1:ENST00000367579:missense_variant:MODERATE:exon2/6:c.116A>G:p.His39Arg:PF00129,MR1:ENST00000367580:missense_variant:MODERATE:exon2/6:c.116A>G:p.His39Arg:PF00129,MR1:ENST00000434571:missense_variant:MODERATE:exon2/4:c.116A>G:p.His39Arg:PF00129			129620 [likely benign DISEASE=not specified];			rs2236410	0.1929	0.1772	423,.	0.1328,0.2421,0.3485,0.1475,0.1755	0.4300	T(0.44),T(0.49),T(0.19),T(0.22)	B(0.08),B(0.17),B(0.27),B(0.07)	0.04,0.14	0.07	0.04				COSM3997106	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181021483	181021483	C	T	het		QUAL=11416;DP=973;AF=0.48;MQM=60	MR1	intron,synonymous	MR1:ENST00000282990:intron_variant:MODIFIER:exon3/4:c.605-1226C>T::,MR1:ENST00000367579:synonymous_variant:LOW:exon4/6:c.582C>T:p.Asn194=:PF07654,MR1:ENST00000367580:synonymous_variant:LOW:exon4/6:c.717C>T:p.Asn239=:PF07654,MR1:ENST00000434571:intron_variant:MODIFIER:exon3/3:c.604+2061C>T::						rs35223984	0.0096	0.0238	12,.	0.0066,0.0075,0.0001,0.0370,0.0015	-1.9970			0.00,0.92	6.26						8	432	2 / 33					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181022518	181022519	AA	-	het		QUAL=4587;DP=300;AF=0.18;MQM=60	MR1	intron	MR1:ENST00000282990:intron_variant:MODIFIER:exon3/4:c.605-177_605-176del::,MR1:ENST00000367579:intron_variant:MODIFIER:exon4/5:c.746-177_746-176del::,MR1:ENST00000367580:intron_variant:MODIFIER:exon4/5:c.881-177_881-176del::,MR1:ENST00000434571:intron_variant:MODIFIER:exon3/3:c.605-1829_605-1828del::					AluJo (SINE/Alu)	rs1382772069		0.0122	0,.		-0.1470				2.40						0	13	0 / 0					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181022518	181022518	A	-	het		QUAL=4587;DP=300;AF=0.62;MQM=60	MR1	intron	MR1:ENST00000282990:intron_variant:MODIFIER:exon3/4:c.605-176del::,MR1:ENST00000367579:intron_variant:MODIFIER:exon4/5:c.746-176del::,MR1:ENST00000367580:intron_variant:MODIFIER:exon4/5:c.881-176del::,MR1:ENST00000434571:intron_variant:MODIFIER:exon3/3:c.605-1828del::					AluJo (SINE/Alu)	rs35459172		0.4474	1919,.		-0.1470				2.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181022895	181022895	C	A	hom		QUAL=5572;DP=188;AF=1.00;MQM=60	MR1	intron	MR1:ENST00000282990:intron_variant:MODIFIER:exon4/4:c.709+82C>A::,MR1:ENST00000367579:intron_variant:MODIFIER:exon5/5:c.850+82C>A::,MR1:ENST00000367580:intron_variant:MODIFIER:exon5/5:c.985+82C>A::,MR1:ENST00000434571:intron_variant:MODIFIER:exon3/3:c.605-1466C>A::						rs2275469	0.5597	0.4050	3079,.		-0.7040			0.00,0.08	0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	181024404	181024404	G	A	hom		QUAL=5025;DP=186;AF=1.00;MQM=60	MR1	3'UTR	MR1:ENST00000282990:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3G>A::,MR1:ENST00000367579:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3G>A::,MR1:ENST00000367580:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3G>A::,MR1:ENST00000434571:3_prime_UTR_variant:MODIFIER:exon4/4:c.*3G>A::						rs3747956	0.5224	0.4004	2645,.	0.5294,0.5533,0.7515,0.2912,0.4868	0.0560			0.02,0.15	4.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)
chr1	220089352	220089352	A	C	het	off-target	QUAL=1829;DP=203;AF=0.52;MQM=60	SLC30A10	intron	SLC30A10:ENST00000366926:intron_variant:MODIFIER:exon3/3:c.959-62T>G::,SLC30A10:ENST00000536446:intron_variant:MODIFIER:exon3/3:c.224-62T>G::		611146 [GENE=SLC30A10 PHENOS=Hypermanganesemia with dystonia 1,613280,Autosomal recessive];				rs2231734	0.2925	0.3142	1632,.		-0.5990			0.01,0.24	1.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC30A10 (inh=AR oe_syn=0.98 oe_mis=0.73 oe_lof=0.00)
chr2	75276429	75276429	C	G	het		QUAL=4675;DP=390;AF=0.49;MQM=60	TACR1	3'UTR	TACR1:ENST00000305249:3_prime_UTR_variant:MODIFIER:exon5/5:c.*130G>C::					MIR3 (SINE/MIR)	rs881	0.2220	0.1767	487,.		-0.3630			0.01,0.14	1.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)
chr2	75425623	75425623	G	A	het		QUAL=7417;DP=682;AF=0.46;MQM=60	TACR1	intron	TACR1:ENST00000305249:intron_variant:MODIFIER:exon1/4:c.389+49C>T::,TACR1:ENST00000409848:intron_variant:MODIFIER:exon1/3:c.389+49C>T::						rs2024512	0.5409	0.5451	4975,.	0.8042,0.4415,0.4058,0.4642,0.3919	-0.9380			0.00,0.10	5.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)
chr2	75425728	75425728	A	G	het		QUAL=9618;DP=823;AF=0.50;MQM=60	TACR1	synonymous	TACR1:ENST00000305249:synonymous_variant:LOW:exon1/5:c.333T>C:p.Phe111=:PF00001,TACR1:ENST00000409848:synonymous_variant:LOW:exon1/4:c.333T>C:p.Phe111=:PF00001						rs6715729	0.5651	0.5683	5509,.	0.8609,0.4565,0.4070,0.4755,0.4001	1.1620			0.19,0.96	14.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)
chr2	147596973	147596973	A	G	het		QUAL=2498;DP=309;AF=0.46;MQM=60	AC103881.1	intron&non_coding_transcript	AC103881.1:ENST00000450667:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/5:n.229+1200A>G::						rs4411641	0.5090	0.4872	3884,.	0.6458,0.6144,0.4402,0.3990,0.4075	0.2240			0.00,0.04	5.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AC103881.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	179306614	179306614	-	T	het		QUAL=10;DP=16;AF=0.25;MQM=55	PRKRA	intron	PRKRA:ENST00000325748:intron_variant:MODIFIER:exon5/7:c.515-184dup::,PRKRA:ENST00000432031:intron_variant:MODIFIER:exon4/6:c.482-184dup::,PRKRA:ENST00000438687:intron_variant:MODIFIER:exon6/8:c.176-184dup::,PRKRA:ENST00000487082:intron_variant:MODIFIER:exon5/7:c.440-184dup::		603424 [GENE=PRKRA PHENOS=Dystonia 16,612067,Autosomal recessive];			AluSx1 (SINE/Alu)	rs541455452	0.2949	0.2969	1177,.						2.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKRA (inh=AR oe_syn=0.83 oe_mis=0.65 oe_lof=0.22)
chr2	219206919	219206919	C	T	het	off-target	QUAL=12368;DP=957;AF=0.53;MQM=60	PNKD,AC021016.8	intron,intron&non_coding_transcript	PNKD:ENST00000258362:intron_variant:MODIFIER:exon6/8:c.709+52C>T::,PNKD:ENST00000273077:intron_variant:MODIFIER:exon7/9:c.781+52C>T::,AC021016.8:ENST00000411433:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.120+8964G>A::,PNKD:ENST00000436005:intron_variant:MODIFIER:exon6/8:c.601+52C>T::		609023 [GENE=PNKD PHENOS=Paroxysmal nonkinesigenic dyskinesia 1,118800,Autosomal dominant];				rs3816562	0.4800	0.5364	3483,.	0.2152,0.5844,0.6360,0.5261,0.6358	0.1850			0.05,0.35	6.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNKD (inh=AD oe_syn=0.86 oe_mis=0.94 oe_lof=0.73), AC021016.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	123010276	123010276	G	A	het	off-target	QUAL=11802;DP=1054;AF=0.47;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon17/20:c.2014-53C>T::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon17/20:c.3064-53C>T::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon19/22:c.2038-53C>T::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9809236	0.1829	0.2969	1716,.		0.7360			0.05,0.10	0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123014877	123014877	C	T	hom	off-target	QUAL=35015;DP=1120;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon17/20:c.2013+54G>A::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon17/20:c.3063+54G>A::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon19/22:c.2037+54G>A::	regulatory_region_variant:CTCF_binding_site	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9881951	0.7206	0.7149	8228,.		-0.6560			0.01,0.14	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123015094	123015094	G	C	hom	off-target	QUAL=3809;DP=167;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon16/20:c.1881-31C>G::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon16/20:c.2931-31C>G::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon18/22:c.1905-31C>G::	regulatory_region_variant:CTCF_binding_site	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9882534		0.9967	15275,.	0.9535,0.9986,0.9999,0.9999,0.9999	-2.5510			0.02,0.10	1.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123018963	123018963	A	G	hom		QUAL=45815;DP=1468;AF=1.00;MQM=60	ADCY5	splice_region&intron	ADCY5:ENST00000309879:splice_region_variant&intron_variant:LOW:exon15/20:c.1850+4T>C::,ADCY5:ENST00000462833:splice_region_variant&intron_variant:LOW:exon15/20:c.2900+4T>C::,ADCY5:ENST00000491190:splice_region_variant&intron_variant:LOW:exon16/22:c.1799+4T>C::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4482616	0.8067	0.8069	10211,.	0.7982,0.7885,0.8768,0.8060,0.7881	-1.1070			0.01,0.10	0.06		3.93>4.57		0.000/0.006		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123021838	123021838	A	G	hom	off-target	QUAL=15994;DP=570;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon14/20:c.1674+64T>C::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon14/20:c.2724+64T>C::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon15/22:c.1623+64T>C::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9877581	0.9834	0.9873	15299,.		-0.9570			0.00,0.06	9.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123021870	123021870	G	C	het	off-target	QUAL=14537;DP=1129;AF=0.49;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon14/20:c.1674+32C>G::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon14/20:c.2724+32C>G::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon15/22:c.1623+32C>G::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9844212	0.4417	0.5511	4876,.	0.4767,0.3814,0.3040,0.5847,0.4717	-2.4670			0.00,0.07	0.04			gain/donor/123021870-123021871/Medium/1.592649			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123047478	123047478	A	G	het		QUAL=5441;DP=590;AF=0.39;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon6/20:c.755+13T>C::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon6/20:c.1805+13T>C::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon7/22:c.704+13T>C::	regulatory_region_variant:CTCF_binding_site	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9855635	0.2153	0.3003	1544,.	0.1223,0.1537,0.2690,0.3710,0.2535	-1.7890			0.02,0.11	0.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123047666	123047666	A	G	hom		QUAL=25229;DP=804;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon5/20:c.597-17T>C::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon5/20:c.1647-17T>C::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon6/22:c.546-17T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9855969	0.8852	0.8617	11707,.	0.9119,0.8026,0.9635,0.8405,0.8739	1.3380			0.59,0.88	17.89		8.97>9.78				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123049678	123049678	C	T	het	off-target	QUAL=5393;DP=448;AF=0.49;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon5/20:c.596+58G>A::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon5/20:c.1646+58G>A::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon6/22:c.545+58G>A::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4678009	0.2977	0.2121	784,.		-1.1200			0.02,0.11	0.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123049707	123049707	G	T	het	off-target	QUAL=4680;DP=681;AF=0.34;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon5/20:c.596+29C>A::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon5/20:c.1646+29C>A::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon6/22:c.545+29C>A::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9829332	0.2348	0.3136	1580,.	0.2475,0.1577,0.2651,0.3508,0.1985	-2.0940			0.01,0.09	0.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123049938	123049938	A	C	hom	off-target	QUAL=752;DP=27;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon4/20:c.469-75T>G::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon4/20:c.1519-75T>G::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon5/22:c.418-75T>G::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs6806529	0.6923	0.6311	6360,.		-0.1340			0.02,0.80	15.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123066555	123066555	-	AAGG	hom	off-target	QUAL=2010;DP=229;AF=0.52;MQM=60	ADCY5	intron	ADCY5:ENST00000309879:intron_variant:MODIFIER:exon3/20:c.356+70_356+73dup::,ADCY5:ENST00000462833:intron_variant:MODIFIER:exon3/20:c.1406+70_1406+73dup::,ADCY5:ENST00000491190:intron_variant:MODIFIER:exon4/22:c.305+70_305+73dup::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs112525497	0.9926	0.9941	15482,.						3.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	123167249	123167249	G	A	hom		QUAL=18342;DP=635;AF=1.00;MQM=60	ADCY5	synonymous	ADCY5:ENST00000462833:synonymous_variant:LOW:exon1/21:c.144C>T:p.Gly48=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4678027		0.9990	15124,.	0.9671,0.9978,1.0000,1.0000,0.9998	0.2620			0.23,1.00	7.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)
chr3	148896430	148896430	A	G	het		QUAL=7785;DP=458;AF=0.61;MQM=60	CP	intron	CP:ENST00000264613:intron_variant:MODIFIER:exon15/18:c.2662-12T>C::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];	194589 [benign DISEASE=Deficiency of ferroxidase,not specified];			rs16861582	0.3423	0.3460	1924,.	0.4445,0.2079,0.3683,0.2864,0.2913	0.0930			0.18,0.20	4.74		8.45>8.38		0.000/0.004		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr3	148897499	148897500	AC	-	het		QUAL=877;DP=136;AF=0.30;MQM=60	CP	intron	CP:ENST00000264613:intron_variant:MODIFIER:exon14/18:c.2555-51_2555-50del::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];			(AC)n (Simple_repeat)	rs146148959		0.1586	198,.	0.1512,0.1123,0.0618,0.1846,0.1822	2.2070				1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr3	148897498	148897498	-	AC	het		QUAL=877;DP=136;AF=0.31;MQM=60	CP	intron	CP:ENST00000264613:intron_variant:MODIFIER:exon14/18:c.2555-51_2555-50dup::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];			(AC)n (Simple_repeat)	rs372473602	0.3141	0.2751	1044,.	0.1182,0.2472,0.2675,0.1835,0.1993					2.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr3	148916235	148916235	T	A	hom		QUAL=97;DP=4;AF=1.00;MQM=40	CP	missense	CP:ENST00000264613:missense_variant:MODERATE:exon9/19:c.1632A>T:p.Glu544Asp:	regulatory_region_variant:promoter	117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];	198992 [benign DISEASE=not specified];			rs701753	0.8622	0.9227	12247,.	0.6883,0.9558,0.9996,0.9411,0.8750	-0.0800	T(1.00)	B(0.00)	0.12,0.84	11.93	0.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr3	148930218	148930218	G	A	het		QUAL=1169;DP=150;AF=0.47;MQM=60	CP	intron	CP:ENST00000264613:intron_variant:MODIFIER:exon2/18:c.394+20C>T::	regulatory_region_variant:TF_binding_site	117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];				rs17847023	0.1394	0.1309	258,.	0.0205,0.1713,0.3857,0.0936,0.1469	-0.2150			0.04,0.20	11.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr3	148935893	148935893	A	G	het		QUAL=549;DP=62;AF=0.53;MQM=60	CP	intron	CP:ENST00000264613:intron_variant:MODIFIER:exon1/18:c.146+3541T>C::		117700 [GENE=CP PHENOS=Cerebellar ataxia,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Hypoceruloplasminemia,hereditary,604290,Autosomal recessive];				rs16861636	0.1424	0.1007	238,.		0.3360			0.00,0.04	7.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)
chr4	185999587	185999587	T	A	het	off-target	QUAL=583;DP=55;AF=0.55;MQM=60	RP11-386B13.3	intron&non_coding_transcript	RP11-386B13.3:ENST00000509017:intron_variant&non_coding_transcript_variant:MODIFIER:exon5/8:n.1340+6360T>A::	regulatory_region_variant:promoter_flanking_region					rs6818170	0.6675	0.6819	7483,.	0.8328,0.5467,0.4189,0.6699,0.6606	0.4470			0.00,0.11	10.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RP11-386B13.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	1394815	1394815	A	G	het		QUAL=4018;DP=291;AF=0.57;MQM=60	SLC6A3	3'UTR	SLC6A3:ENST00000270349:3_prime_UTR_variant:MODIFIER:exon15/15:c.*35T>C::,SLC6A3:ENST00000453492:3_prime_UTR_variant:MODIFIER:exon14/15:c.*35T>C::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs1042098	0.2951	0.2925	1532,.	0.4599,0.1696,0.0967,0.2668,0.2278	-0.8700			0.00,0.08	4.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)
chr5	1409127	1409127	T	C	hom		QUAL=21519;DP=734;AF=1.00;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349:intron_variant:MODIFIER:exon11/14:c.1498+14A>G::,SLC6A3:ENST00000453492:intron_variant:MODIFIER:exon10/14:c.1498+14A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];	518359 [benign DISEASE=Infantile Parkinsonism-dystonia];			rs429699	0.9367	0.9812	15148,.	0.9952,0.8544,0.7537,0.9990,0.9850	0.2120			0.00,0.22	0.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)
chr5	1416142	1416142	C	A	het		QUAL=6602;DP=496;AF=0.55;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349:intron_variant:MODIFIER:exon7/14:c.1031+71G>T::,SLC6A3:ENST00000453492:intron_variant:MODIFIER:exon6/14:c.1031+71G>T::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs40358		0.8144	10509,.		-3.3320			0.00,0.04	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)
chr5	1416646	1416646	G	A	het		QUAL=301;DP=37;AF=0.57;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349:intron_variant:MODIFIER:exon6/14:c.928-330C>T::,SLC6A3:ENST00000453492:intron_variant:MODIFIER:exon5/14:c.928-330C>T::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs2042449	0.1865	0.2091	685,.		-1.0500			0.00,0.09	0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)
chr5	1443199	1443199	G	A	het		QUAL=28022;DP=1860;AF=0.54;MQM=60	SLC6A3	synonymous	SLC6A3:ENST00000270349:synonymous_variant:LOW:exon2/15:c.114C>T:p.Asn38=:,SLC6A3:ENST00000453492:synonymous_variant:LOW:exon1/15:c.114C>T:p.Asn38=:		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];	522348 [benign DISEASE=Infantile Parkinsonism-dystonia];			rs6350	0.0455	0.0562	49,.	0.0516,0.0343,0.0184,0.0639,0.0596	-0.2160			0.17,0.74	0.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)
chr5	57617403	57617403	G	C	het		QUAL=4497;DP=377;AF=0.50;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MLT1E1A (LTR/ERVL-MaLR)	rs37535		0.5798	5303,.		0.8490			0.01,0.11	1.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	149433596	149433596	T	G	het	off-target	QUAL=4039;DP=613;AF=0.36;MQM=60	CSF1R	3'UTR	CSF1R:ENST00000286301:3_prime_UTR_variant:MODIFIER:exon22/22:c.*36A>C::	regulatory_region_variant:promoter_flanking_region	164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352120 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066934	0.7967	0.8260	10677,.	0.9495,0.7787,0.7349,0.7624,0.6831	0.8170			0.00,0.11	0.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149433597	149433597	G	A	het	off-target	QUAL=4039;DP=613;AF=0.36;MQM=60	CSF1R	3'UTR	CSF1R:ENST00000286301:3_prime_UTR_variant:MODIFIER:exon22/22:c.*35C>T::	regulatory_region_variant:promoter_flanking_region	164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352121 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066933	0.7959	0.8256	10662,.	0.9496,0.7784,0.7279,0.7623,0.6829	-0.2550			0.00,0.10	3.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149435608	149435608	G	C	het		QUAL=16182;DP=1323;AF=0.46;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301:synonymous_variant:LOW:exon19/22:c.2535C>G:p.Leu845=:PF07714		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352132 [benign/likely benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs56327604	0.0126	0.0310	24,.	0.0077,0.0220,0.0000,0.0471,0.0074	1.2680			0.83,0.94	19.04					COSM5020601	8	589	1 / 47					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149435759	149435759	G	A	het		QUAL=2919;DP=316;AF=0.46;MQM=60	CSF1R	intron	CSF1R:ENST00000286301:intron_variant:MODIFIER:exon18/21:c.2442+23C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216136	0.3942	0.5282	4356,.	0.1632,0.4053,0.4655,0.6025,0.5138	-0.0250			0.10,0.21	6.06			gain/donor/149435758-149435759/Medium/0.818332			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149437190	149437190	C	G	het	off-target	QUAL=17334;DP=1533;AF=0.45;MQM=60	CSF1R	intron	CSF1R:ENST00000286301:intron_variant:MODIFIER:exon15/21:c.2133-35G>C::	regulatory_region_variant:promoter_flanking_region	164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216138	0.7919	0.8222	10668,.	0.9499,0.7764,0.7286,0.7583,0.6777	0.2340			0.00,0.08	7.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149441017	149441017	C	-	het	off-target	QUAL=643;DP=106;AF=0.46;MQM=60	CSF1R	intron	CSF1R:ENST00000286301:intron_variant:MODIFIER:exon13/21:c.1858+37del::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs11286566	0.3892	0.5645	3861,.	0.1862,0.4819,0.5179,0.6266,0.5560	-0.2690				0.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149456771	149456771	C	A	het	off-target	QUAL=7835;DP=679;AF=0.49;MQM=60	CSF1R	intron	CSF1R:ENST00000286301:intron_variant:MODIFIER:exon6/21:c.889+68G>T::,CSF1R:ENST00000543093:intron_variant:MODIFIER:exon5/5:c.889+68G>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs2855781	0.3097	0.4464	3500,.	0.2608,0.3440,0.0792,0.5244,0.4370	0.3710			0.11,0.20	6.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149456772	149456772	T	A	het	off-target	QUAL=7835;DP=679;AF=0.49;MQM=60	CSF1R	intron	CSF1R:ENST00000286301:intron_variant:MODIFIER:exon6/21:c.889+67A>T::,CSF1R:ENST00000543093:intron_variant:MODIFIER:exon5/5:c.889+67A>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs60844779	0.3097	0.4463	3502,.	0.2606,0.3439,0.0792,0.5242,0.4370	0.0350			0.11,0.19	6.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149457678	149457678	G	A	het		QUAL=25640;DP=2089;AF=0.47;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301:synonymous_variant:LOW:exon5/22:c.726C>T:p.Thr242=:PF00047,CSF1R:ENST00000543093:synonymous_variant:LOW:exon4/6:c.726C>T:p.Thr242=:PF00047		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352165 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];	CM153945 [CLASS=FP MUT=ALT PHEN="Loss of enhancer activity" GENE=CSF1R];		rs2228422	0.3874	0.5103	4312,.	0.3201,0.4155,0.2189,0.5676,0.5550	0.0190			0.45,0.93	5.70					COSM4159635	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149460553	149460553	A	G	het		QUAL=22910;DP=1838;AF=0.49;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301:synonymous_variant:LOW:exon3/22:c.84T>C:p.Pro28=:PF13927,CSF1R:ENST00000543093:synonymous_variant:LOW:exon2/6:c.84T>C:p.Pro28=:PF13927		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352179 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs216123	0.3353	0.4823	4117,.	0.2921,0.3591,0.0952,0.5669,0.4657	-0.8850			0.04,0.36	4.51					COSM4407262	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr6	131148863	131148863	A	T	het		QUAL=2268;DP=184;AF=0.53;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron_variant:MODIFIER:exon1/1:c.238+72A>T::	regulatory_region_variant:promoter					rs9388856	0.4794	0.3781	2349,.		0.0190			0.08,0.21	0.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	131148891	131148891	-	AT	het	off-target	QUAL=2264;DP=258;AF=0.39;MQM=60	SMLR1	intron	SMLR1:ENST00000541421:intron_variant:MODIFIER:exon1/1:c.238+113_238+114dup::	regulatory_region_variant:promoter					rs113795427	0.4884	0.3951	2416,.						1.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	161807855	161807855	C	G	het		QUAL=9773;DP=732;AF=0.51;MQM=60	PRKN	missense	PRKN:ENST00000338468:missense_variant:MODERATE:exon9/11:c.565G>C:p.Val189Leu:,PRKN:ENST00000366894:missense_variant:MODERATE:exon9/11:c.565G>C:p.Val189Leu:,PRKN:ENST00000366896:missense_variant:MODERATE:exon7/9:c.691G>C:p.Val231Leu:,PRKN:ENST00000366897:missense_variant:MODERATE:exon9/11:c.1054G>C:p.Val352Leu:,PRKN:ENST00000366898:missense_variant:MODERATE:exon10/12:c.1138G>C:p.Val380Leu:		602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];	41221 [benign/likely benign DISEASE=Parkinson Disease, Juvenile,Parkinson disease 2,not specified];	CM032983 [CLASS=DP MUT=ALT PHEN="Parkinson disease sporadic reduced risk" GENE=PRKN];		rs1801582	0.1721	0.1641	403,.	0.1725,0.1174,0.0786,0.1614,0.2632	-0.3990	T(0.48),T(0.48),T(0.58),T(0.46),T(0.44)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.09	9.83	0.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)			n/a (2xTP, 0xFP)		PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	161990483	161990483	C	T	hom		QUAL=9783;DP=324;AF=1.00;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon6/10:c.299-35G>A::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon7/9:c.872-35G>A::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon6/10:c.299-35G>A::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon4/8:c.425-35G>A::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon6/10:c.788-35G>A::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon7/11:c.872-35G>A::		602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];				rs3765474	0.5781	0.5579	4840,.	0.5323,0.4027,0.6961,0.5517,0.5583	-0.3760			0.00,0.12	4.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	161990516	161990516	G	C	hom		QUAL=14488;DP=447;AF=1.00;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon6/10:c.299-68C>G::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon7/9:c.872-68C>G::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon6/10:c.299-68C>G::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon4/8:c.425-68C>G::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon6/10:c.788-68C>G::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon7/11:c.872-68C>G::		602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];				rs3765475	0.6895	0.6694	7120,.		0.0370			0.00,0.06	3.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	162622304	162622304	A	G	het		QUAL=7123;DP=608;AF=0.51;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon3/10:c.-40+61253T>C::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon3/9:c.413-20T>C::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon2/10:c.-161-20T>C::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon2/8:c.172-227855T>C::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon3/10:c.413-20T>C::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon3/11:c.413-20T>C::	regulatory_region_variant:enhancer	602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];	259433 [benign DISEASE=not specified];	CS046043 [CLASS=DP MUT=ALT PHEN="Parkinson disease association with" GENE=PRKN];		rs4709583	0.9505	0.9475	14087,.	0.9842,0.9637,0.9881,0.9182,0.8933	0.2890			0.00,0.16	3.36		9.80>10.02				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	162683815	162683815	A	-	het		QUAL=1208;DP=1040;AF=0.19;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon2/10:c.-280-18del::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon2/9:c.172-18del::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon2/10:c.-161-61531del::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon2/8:c.171+180527del::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon2/10:c.172-18del::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon2/11:c.172-18del::	regulatory_region_variant:promoter_flanking_region	602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];			(A)n (Simple_repeat)	rs756249386		0.0497	1,.		-0.0420				0.02						203	1913	9 / 192					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	162864317	162864317	A	G	het		QUAL=4677;DP=430;AF=0.49;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon2/10:c.-281+25T>C::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon2/9:c.171+25T>C::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon2/10:c.-162+25T>C::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon2/8:c.171+25T>C::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon2/10:c.171+25T>C::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon2/11:c.171+25T>C::		602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];				rs2075923	0.2734	0.2948	1420,.	0.3920,0.2805,0.1785,0.2310,0.2184	2.3010			0.03,0.12	5.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr6	162864839	162864839	A	G	het		QUAL=469;DP=43;AF=0.79;MQM=60	PRKN	intron	PRKN:ENST00000338468:intron_variant:MODIFIER:exon1/10:c.-444-334T>C::,PRKN:ENST00000366892:intron_variant:MODIFIER:exon1/9:c.8-334T>C::,PRKN:ENST00000366894:intron_variant:MODIFIER:exon1/10:c.-325-334T>C::,PRKN:ENST00000366896:intron_variant:MODIFIER:exon1/8:c.8-334T>C::,PRKN:ENST00000366897:intron_variant:MODIFIER:exon1/10:c.8-334T>C::,PRKN:ENST00000366898:intron_variant:MODIFIER:exon1/11:c.8-334T>C::		602544 [GENE=PRKN PHENOS=Adenocarcinoma of lung,somatic,211980/Ovarian cancer,somatic,167000/Parkinson disease,juvenile,type 2,600116,Autosomal recessive];				rs10455909	0.2208	0.2593	1056,.		1.9240			0.05,0.20	3.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)
chr7	94227276	94227276	T	G	het		QUAL=1816;DP=214;AF=0.42;MQM=60	SGCE	intron,missense	SGCE:ENST00000265735:intron_variant:MODIFIER:exon9/10:c.1253+811A>C::,SGCE:ENST00000415788:intron_variant:MODIFIER:exon10/10:c.1361+811A>C::,SGCE:ENST00000428696:intron_variant:MODIFIER:exon8/10:c.1226+811A>C::,SGCE:ENST00000437425:intron_variant:MODIFIER:exon8/9:c.1130+811A>C::,SGCE:ENST00000445866:missense_variant:MODERATE:exon10/12:c.1294A>C:p.Ser432Arg:PF13900,SGCE:ENST00000447873:intron_variant:MODIFIER:exon8/9:c.1226+811A>C::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];	487363 [benign DISEASE=Myoclonic dystonia];	CM173553 [CLASS=R MUT=ALT PHEN="Myoclonus dystonia" GENE=SGCE];	AluSq2 (SINE/Alu)	rs10247562		0.7880	9679,.	0.9643,0.4915,0.6939,0.6891,0.5588	-0.8570	 , , , ,T(0.12), 	 , , , ,B(0.00), 	0.00,0.02	6.95	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)
chr7	94227509	94227509	G	A	het		QUAL=89;DP=15;AF=0.47;MQM=60	SGCE	intron	SGCE:ENST00000265735:intron_variant:MODIFIER:exon9/10:c.1253+578C>T::,SGCE:ENST00000415788:intron_variant:MODIFIER:exon10/10:c.1361+578C>T::,SGCE:ENST00000428696:intron_variant:MODIFIER:exon8/10:c.1226+578C>T::,SGCE:ENST00000437425:intron_variant:MODIFIER:exon8/9:c.1130+578C>T::,SGCE:ENST00000445866:intron_variant:MODIFIER:exon9/11:c.1254-193C>T::,SGCE:ENST00000447873:intron_variant:MODIFIER:exon8/9:c.1226+578C>T::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs10232398	0.7630	0.7888	9871,.		-1.1440			0.00,0.07	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)
chr7	94252752	94252752	T	G	het		QUAL=773;DP=99;AF=0.41;MQM=60	SGCE	intron	SGCE:ENST00000265735:intron_variant:MODIFIER:exon3/10:c.391-43A>C::,SGCE:ENST00000415788:intron_variant:MODIFIER:exon4/10:c.499-43A>C::,SGCE:ENST00000428696:intron_variant:MODIFIER:exon3/10:c.391-43A>C::,SGCE:ENST00000437425:intron_variant:MODIFIER:exon2/9:c.268-43A>C::,SGCE:ENST00000445866:intron_variant:MODIFIER:exon3/11:c.391-43A>C::,SGCE:ENST00000447873:intron_variant:MODIFIER:exon3/9:c.391-43A>C::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];	259198 [benign DISEASE=Myoclonic dystonia,not specified];			rs2272091	0.1448	0.1619	281,.	0.0219,0.1738,0.2330,0.1356,0.2477	0.8220			0.21,0.35	15.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)
chr7	94273994	94273994	A	G	het		QUAL=1266;DP=110;AF=0.45;MQM=60	SGCE	intron	SGCE:ENST00000265735:intron_variant:MODIFIER:exon1/10:c.109+11308T>C::,SGCE:ENST00000415788:intron_variant:MODIFIER:exon1/10:c.110-5234T>C::,SGCE:ENST00000428696:intron_variant:MODIFIER:exon1/10:c.109+11308T>C::,SGCE:ENST00000437425:intron_variant:MODIFIER:exon1/9:c.109+11308T>C::,SGCE:ENST00000445866:intron_variant:MODIFIER:exon1/11:c.109+11308T>C::,SGCE:ENST00000447873:intron_variant:MODIFIER:exon1/9:c.109+11308T>C::	regulatory_region_variant:promoter_flanking_region	604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs35016618	0.1703	0.1676	362,.	0.1094,0.1726,0.2259,0.1322,0.2387	-1.3430			0.01,0.10	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)
chr7	94274032	94274032	T	C	het		QUAL=888;DP=76;AF=0.47;MQM=60	SGCE	intron	SGCE:ENST00000265735:intron_variant:MODIFIER:exon1/10:c.109+11270A>G::,SGCE:ENST00000415788:intron_variant:MODIFIER:exon1/10:c.110-5272A>G::,SGCE:ENST00000428696:intron_variant:MODIFIER:exon1/10:c.109+11270A>G::,SGCE:ENST00000437425:intron_variant:MODIFIER:exon1/9:c.109+11270A>G::,SGCE:ENST00000445866:intron_variant:MODIFIER:exon1/11:c.109+11270A>G::,SGCE:ENST00000447873:intron_variant:MODIFIER:exon1/9:c.109+11270A>G::	regulatory_region_variant:promoter_flanking_region	604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs13241095	0.1530	0.1284	311,.		-0.1680			0.02,0.17	4.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)
chr8	42295131	42295131	T	-	het	off-target	QUAL=34;DP=423;AF=0.14;MQM=60	SLC20A2	intron	SLC20A2:ENST00000342228:intron_variant:MODIFIER:exon7/10:c.935-36del::,SLC20A2:ENST00000520179:intron_variant:MODIFIER:exon7/10:c.935-36del::,SLC20A2:ENST00000520262:intron_variant:MODIFIER:exon7/10:c.935-36del::		158378 [GENE=SLC20A2 PHENOS=Basal ganglia calcification,idiopathic,1,213600,Autosomal dominant];			AluSx3 (SINE/Alu)	rs763972652		0.2461	0,.	0.2238,0.2533,0.2517,0.2500,0.2580	0.3580				2.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC20A2 (inh=AD oe_syn=1.14 oe_mis=0.63 oe_lof=0.14)
chr8	107236280	107236280	G	T	hom		QUAL=838;DP=29;AF=1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.6096	0.5562	5348,.		-0.5990			0.00,0.05	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr9	5921881	5921881	G	A	het		QUAL=8251;DP=688;AF=0.46;MQM=60	KIAA2026	missense	KIAA2026:ENST00000381461:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:						rs72697396	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	1.9050	D(0.02),D(0.02)	B(0.08),B(0.08)	0.39,0.53	15.26	0.03					0	9	0 / 1					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	79792920	79792920	G	T	hom		QUAL=2361;DP=93;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon1/68:c.100+200G>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon1/71:c.100+200G>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon1/68:c.100+200G>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon1/70:c.100+200G>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs45463897	0.0791	0.0967	176,.		-2.5480			0.02,0.35	0.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79814799	79814799	A	G	hom		QUAL=14987;DP=483;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon1/68:c.101-62A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon1/71:c.101-62A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon1/68:c.101-62A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon1/70:c.101-62A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs12552898	0.5463	0.5045	4010,.		-0.1940			0.00,0.08	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79820141	79820141	-	T	hom		QUAL=115;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon3/68:c.188-88_188-87insT::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon3/71:c.188-88_188-87insT::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon3/68:c.188-88_188-87insT::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon3/70:c.188-88_188-87insT::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs75101662	0.6126	0.5549	4754,.						3.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79828406	79828406	C	T	hom		QUAL=170;DP=12;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon9/68:c.696+176C>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon9/71:c.696+176C>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon9/68:c.696+176C>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon9/70:c.696+176C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72742573	0.0471	0.0496	50,.		-0.1330			0.01,0.16	0.67						3	7	0 / 0					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79828414	79828417	TTTT	-	hom		QUAL=37;DP=20;AF=0.25;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon9/68:c.696+197_696+200del::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon9/71:c.696+197_696+200del::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon9/68:c.696+197_696+200del::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon9/70:c.696+197_696+200del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluJr (SINE/Alu)			0.0001	0,.		0.9580				1.24						1	1	0 / 0					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79828516	79828516	A	G	hom		QUAL=1249;DP=51;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon9/68:c.696+286A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon9/71:c.696+286A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon9/68:c.696+286A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon9/70:c.696+286A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluJr (SINE/Alu)	rs72742574	0.0479	0.0507	51,.		-1.8570			0.00,0.05	0.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79829077	79829077	A	G	hom		QUAL=1309;DP=57;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon9/68:c.697-168A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon9/71:c.697-168A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon9/68:c.697-168A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon9/70:c.697-168A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluSz (SINE/Alu)	rs145189157	0.0471	0.0508	51,.		0.3490			0.01,0.11	3.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79835177	79835177	A	C	hom		QUAL=247;DP=8;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon11/68:c.883-16A>C::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon11/71:c.883-16A>C::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon11/68:c.883-16A>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon11/70:c.883-16A>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72742584	0.0471	0.0676	51,.	0.0154,0.0293,0.0005,0.0880,0.1239	0.4050			0.28,0.23	1.63		6.56>7.47				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79835313	79835313	T	-	het		QUAL=310;DP=74;AF=0.27;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon12/68:c.989+28del::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon12/71:c.989+28del::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon12/68:c.989+28del::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon12/70:c.989+28del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367349 [uncertain significance DISEASE=Choreoacanthocytosis];			rs761049193		0.3637	18,.	0.2880,0.3765,0.3331,0.3590,0.3916	-0.5550				0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79841043	79841043	T	C	hom		QUAL=124;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon14/68:c.1224+139T>C::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon14/71:c.1224+139T>C::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon14/68:c.1224+139T>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon14/70:c.1224+139T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs55943354	0.0479	0.0507	50,.		0.0530			0.16,0.45	14.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79852887	79852887	C	T	hom		QUAL=139;DP=6;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon17/68:c.1596-31C>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon17/71:c.1596-31C>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon17/68:c.1596-31C>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon17/70:c.1596-31C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72742601	0.0465	0.0668	50,.	0.0149,0.0295,0.0005,0.0878,0.1192	0.0710			0.00,0.16	1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79862502	79862502	T	C	hom		QUAL=1196;DP=41;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon20/68:c.2037+191T>C::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon20/71:c.2037+191T>C::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon20/68:c.2037+191T>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon20/70:c.2037+191T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs10115162	0.1891	0.2015	674,.		-0.0820			0.04,0.16	3.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79865187	79865187	G	A	hom		QUAL=1894;DP=62;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon21/68:c.2170+42G>A::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon21/71:c.2170+42G>A::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon21/68:c.2170+42G>A::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon21/70:c.2170+42G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2021998	0.1893	0.2015	675,.	0.2409,0.1107,0.0495,0.2063,0.2254	0.3390			0.03,0.19	0.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79875259	79875259	G	A	hom		QUAL=28;DP=6;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon23/68:c.2427+119G>A::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon23/71:c.2427+119G>A::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon23/68:c.2427+119G>A::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon23/70:c.2427+119G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs879011403					-0.5740			0.00,0.09	1.18						30	8	0 / 0	2	[2] auto-classification 07.11.2017  			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79888396	79888396	A	G	hom		QUAL=88;DP=3;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon24/68:c.2512+116A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon24/71:c.2512+116A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon24/68:c.2512+116A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon24/70:c.2512+116A>G::	regulatory_region_variant:promoter_flanking_region	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			MER34C_ (LTR/ERV1)	rs2050831		0.8276	10857,.		-2.6870			0.00,0.06	0.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79890727	79890727	C	T	hom		QUAL=427;DP=23;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon25/68:c.2667+159C>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon25/71:c.2667+159C>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon25/68:c.2667+159C>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon25/70:c.2667+159C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs7041795	0.2516	0.2659	945,.		-1.0770			0.00,0.09	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79890738	79890738	A	T	hom	off-target	QUAL=225;DP=14;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon25/68:c.2667+170A>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon25/71:c.2667+170A>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon25/68:c.2667+170A>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon25/70:c.2667+170A>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1206302950		0.0001	0,.		-2.3790			0.00,0.07	0.07						51	0	0 / 0	2	[2] auto-classification 07.11.2017  			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79910407	79910407	A	G	hom		QUAL=1828;DP=58;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon32/68:c.3508-51A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon32/71:c.3508-51A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon32/68:c.3508-51A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon31/70:c.3391-51A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1317305	0.0483	0.0698	50,.	0.0137,0.0334,0.0006,0.0866,0.1208	0.0180			0.13,0.95	13.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79910414	79910414	G	T	hom		QUAL=1825;DP=58;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon32/68:c.3508-44G>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon32/71:c.3508-44G>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon32/68:c.3508-44G>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon31/70:c.3391-44G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1317304	0.2366	0.2772	1224,.	0.2348,0.1451,0.1467,0.3002,0.2917	-0.6280			0.00,0.07	3.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79917660	79917660	C	G	hom		QUAL=1379;DP=57;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon33/68:c.3813-171C>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon33/71:c.3813-171C>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon33/68:c.3813-171C>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon32/70:c.3696-171C>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs17423381	0.0487	0.0540	55,.		-0.6870			0.02,0.16	6.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79922839	79922839	A	G	hom		QUAL=2520;DP=101;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon34/68:c.3961-22A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon34/71:c.3961-22A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon34/68:c.3961-22A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon33/70:c.3844-22A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2275549		0.5585	4264,.	0.5007,0.6508,0.5703,0.5266,0.6262	-0.4630			0.00,0.09	1.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79930342	79930342	C	G	het		QUAL=1090;DP=86;AF=0.52;MQM=60	VPS13A	missense	VPS13A:ENST00000357409:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000360280:missense_variant:MODERATE:exon38/72:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000376634:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000376636:missense_variant:MODERATE:exon37/71:c.4469C>G:p.Thr1490Ser:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72744294	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.1180	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.18,0.23	6.15	0.05					0	2	0 / 0	3	[3] ahsturm1 30.09.2019 test [2] ahsturm1 30.09.2019 test2 [3] ahsturm1 30.09.2019 test3			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79936415	79936415	A	G	hom		QUAL=183;DP=6;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000360280:synonymous_variant:LOW:exon44/72:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000376634:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000376636:synonymous_variant:LOW:exon43/71:c.5466A>G:p.Thr1822=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367389 [benign/likely benign DISEASE=Choreoacanthocytosis,not provided];			rs17423984	0.0487	0.0716	55,.	0.0155,0.0303,0.0006,0.0907,0.1262	0.1020			0.81,0.96	9.33					COSM3764010,COSM3764011,COSM3764012	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79954404	79954405	TG	-	het		QUAL=1896;DP=110;AF=0.25;MQM=59	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon47/68:c.6379-27_6379-26del::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon47/71:c.6379-27_6379-26del::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon47/68:c.6379-27_6379-26del::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon46/70:c.6262-27_6262-26del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs1181116264					0.0000				1.12						5	226	2 / 14					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79954405	79954405	G	T	het		QUAL=1896;DP=110;AF=0.25;MQM=58	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon47/68:c.6379-27G>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon47/71:c.6379-27G>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon47/68:c.6379-27G>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon46/70:c.6262-27G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs56156608		0.0900	114,.		0.0000			0.02,0.16	0.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79954410	79954410	G	T	hom		QUAL=3486;DP=119;AF=0.97;MQM=59	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon47/68:c.6379-22G>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon47/71:c.6379-22G>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon47/68:c.6379-22G>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon46/70:c.6262-22G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs55937672	0.4373	0.3967	1966,.		-0.6630			0.01,0.21	0.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79954545	79954545	T	C	hom		QUAL=5749;DP=191;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000360280:synonymous_variant:LOW:exon48/72:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000376634:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000376636:synonymous_variant:LOW:exon47/71:c.6375T>C:p.Asp2125=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367402 [benign/likely benign DISEASE=Choreoacanthocytosis,not provided];			rs7025532	0.1627	0.1889	586,.	0.2167,0.0800,0.0346,0.1951,0.2069	-0.1050			0.53,0.96	8.98					COSM3764013,COSM3764014,COSM3764015	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79955305	79955305	-	T	hom		QUAL=1269;DP=64;AF=0.95;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon49/68:c.6880-6dup::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon49/71:c.6880-6dup::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon49/68:c.6880-6dup::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon48/70:c.6763-6dup::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367404 [likely benign DISEASE=Choreoacanthocytosis];			rs1294790303		0.2019	663,.	0.2383,0.0880,0.0347,0.2078,0.2196					0.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79959015	79959015	A	G	hom		QUAL=8417;DP=270;AF=0.99;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon50/68:c.7027-54A>G::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon50/71:c.7027-54A>G::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon50/68:c.7027-54A>G::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon49/70:c.6910-54A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72746022	0.0555	0.0612	71,.		-0.4690			0.02,0.14	0.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79972830	79972830	C	T	het		QUAL=17;DP=23;AF=0.65;MQM=59	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon56/68:c.7953+76C>T::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon56/71:c.7953+76C>T::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon56/68:c.7953+76C>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon55/70:c.7836+76C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];									-0.4220			0.01,0.16	2.01						0	1	0 / 0					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79974399	79974399	G	A	hom		QUAL=1353;DP=43;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon58/68:c.8105+81G>A::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon58/71:c.8105+81G>A::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon58/68:c.8105+81G>A::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon57/70:c.7988+81G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs7043232	0.7101	0.6410	6826,.		1.0200			0.00,0.06	7.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79983083	79983083	G	C	hom		QUAL=308;DP=12;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409:intron_variant:MODIFIER:exon62/68:c.8553+31G>C::,VPS13A:ENST00000360280:intron_variant:MODIFIER:exon62/71:c.8553+31G>C::,VPS13A:ENST00000376634:intron_variant:MODIFIER:exon62/68:c.8553+31G>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon61/70:c.8436+31G>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72746094	0.0509	0.0730	57,.	0.0260,0.0311,0.0006,0.0931,0.1256	-0.0330			0.14,0.22	2.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79984232	79984232	T	C	hom		QUAL=266;DP=9;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000360280:synonymous_variant:LOW:exon63/72:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000376634:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000376636:synonymous_variant:LOW:exon62/71:c.8454T>C:p.Tyr2818=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367423 [benign/likely benign DISEASE=Choreoacanthocytosis,not provided];			rs17340192	0.0517	0.0721	58,.	0.0252,0.0305,0.0005,0.0908,0.1251	1.3060			0.92,0.97	8.11					COSM3764016,COSM3764017,COSM3764018	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	79986057	79986057	A	G	hom		QUAL=8765;DP=288;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:PF09333,VPS13A:ENST00000360280:synonymous_variant:LOW:exon67/72:c.9069A>G:p.Gly3023=:PF09333,VPS13A:ENST00000376634:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:PF09333,VPS13A:ENST00000376636:synonymous_variant:LOW:exon66/71:c.8952A>G:p.Gly2984=:PF09333		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367428 [benign DISEASE=Choreoacanthocytosis,not provided];			rs3737289	0.4151	0.4545	2611,.	0.3143,0.5758,0.3741,0.4327,0.5415	-0.1930			0.52,0.97	10.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	80018376	80018376	G	C	hom		QUAL=2190;DP=72;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280:intron_variant:MODIFIER:exon69/71:c.9275+139G>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon68/70:c.9158+139G>C::,VPS13A:ENST00000376646:intron_variant:MODIFIER:exon3/5:c.83+139G>C::,VPS13A:ENST00000484581:intron_variant:MODIFIER:exon2/4:c.83+139G>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs12352196	0.2636	0.2966	1417,.		-2.1050			0.00,0.05	5.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	80021100	80021100	T	C	hom		QUAL=618;DP=25;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280:intron_variant:MODIFIER:exon70/71:c.9399+197T>C::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon69/70:c.9282+197T>C::,VPS13A:ENST00000376646:intron_variant:MODIFIER:exon4/5:c.207+197T>C::,VPS13A:ENST00000484581:intron_variant:MODIFIER:exon3/4:c.207+197T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72748232	0.0499	0.0551	56,.		0.1070			0.03,0.13	4.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	80022415	80022415	A	T	hom		QUAL=124;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280:intron_variant:MODIFIER:exon70/71:c.9400-34A>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon69/70:c.9283-34A>T::,VPS13A:ENST00000376646:intron_variant:MODIFIER:exon4/5:c.208-34A>T::,VPS13A:ENST00000484581:intron_variant:MODIFIER:exon3/4:c.208-34A>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2025846	0.5847	0.5413	4419,.	0.5598,0.5432,0.6901,0.5065,0.6046	-0.4200			0.00,0.11	7.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	80022675	80022675	C	T	hom		QUAL=2259;DP=89;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280:intron_variant:MODIFIER:exon71/71:c.9474+152C>T::,VPS13A:ENST00000376636:intron_variant:MODIFIER:exon70/70:c.9357+152C>T::,VPS13A:ENST00000376646:intron_variant:MODIFIER:exon5/5:c.282+152C>T::,VPS13A:ENST00000484581:intron_variant:MODIFIER:exon4/4:c.282+152C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs62571470	0.2628	0.2916	1359,.		0.3260			0.00,0.08	0.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	80031144	80031144	G	A	hom		QUAL=1345;DP=51;AF=1.00;MQM=60	VPS13A	3'UTR	VPS13A:ENST00000360280:3_prime_UTR_variant:MODIFIER:exon72/72:c.*222G>A::,VPS13A:ENST00000376636:3_prime_UTR_variant:MODIFIER:exon71/71:c.*222G>A::,VPS13A:ENST00000376646:3_prime_UTR_variant:MODIFIER:exon6/6:c.*222G>A::,VPS13A:ENST00000484581:3_prime_UTR_variant:MODIFIER:exon5/5:c.*222G>A::	regulatory_region_variant:promoter_flanking_region	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367437 [likely benign DISEASE=Choreoacanthocytosis];			rs12343797	0.1653	0.1975	653,.		-0.9220			0.01,0.14	0.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)
chr9	90062823	90062823	A	G	hom		QUAL=13467;DP=443;AF=1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs12682834	0.6368	0.6507	5562,.	0.4721,0.6890,0.6846,0.6292,0.7402	-0.5480			0.00,0.26	0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr9	130928633	130928633	C	T	het		QUAL=16663;DP=1440;AF=0.49;MQM=60	CIZ1	missense	CIZ1:ENST00000277465:missense_variant:MODERATE:exon17/17:c.2456G>A:p.Arg819Gln:,CIZ1:ENST00000325721:missense_variant:MODERATE:exon16/16:c.2453G>A:p.Arg818Gln:,CIZ1:ENST00000357558:missense_variant:MODERATE:exon18/18:c.2456G>A:p.Arg819Gln:,CIZ1:ENST00000372938:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:,CIZ1:ENST00000372948:missense_variant:MODERATE:exon18/18:c.2372G>A:p.Arg791Gln:,CIZ1:ENST00000372954:missense_variant:MODERATE:exon17/17:c.2300G>A:p.Arg767Gln:,CIZ1:ENST00000393608:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:,CIZ1:ENST00000538431:missense_variant:MODERATE:exon18/18:c.2618G>A:p.Arg873Gln:,CIZ1:ENST00000541172:missense_variant:MODERATE:exon16/16:c.2237G>A:p.Arg746Gln:			413837 [benign DISEASE=Dystonia];			rs11549260	0.0086	0.0200	5,.	0.0037,0.0141,0.0000,0.0253,0.0142	0.5500	T(0.13),T(0.18),T(0.13),T(0.16),T(0.12),T(0.13),T(0.16),T(0.19),T(0.16)	B(0.02),B(0.07),B(0.02),B(0.10),B(0.13),B(0.03),B(0.10),B(0.14),B(0.10)	0.45,0.88	22.00	0.03					9	441	0 / 37					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130932397	130932398	AC	-	hom		QUAL=28444;DP=922;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465:intron_variant:MODIFIER:exon11/16:c.1860-12_1860-11del::,CIZ1:ENST00000325721:intron_variant:MODIFIER:exon10/15:c.1857-12_1857-11del::,CIZ1:ENST00000357558:intron_variant:MODIFIER:exon12/17:c.1860-12_1860-11del::,CIZ1:ENST00000372938:intron_variant:MODIFIER:exon11/16:c.1944-12_1944-11del::,CIZ1:ENST00000372948:intron_variant:MODIFIER:exon12/17:c.1776-12_1776-11del::,CIZ1:ENST00000372954:intron_variant:MODIFIER:exon11/16:c.1704-12_1704-11del::,CIZ1:ENST00000393608:intron_variant:MODIFIER:exon11/16:c.1944-12_1944-11del::,CIZ1:ENST00000538431:intron_variant:MODIFIER:exon11/17:c.1944-12_1944-11del::,CIZ1:ENST00000541172:intron_variant:MODIFIER:exon10/15:c.1641-12_1641-11del::	regulatory_region_variant:open_chromatin_region					rs144699223	0.4846	0.6129	4570,.	0.1606,0.7536,0.5132,0.6452,0.6584	0.4000				6.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130938661	130938661	C	T	het		QUAL=20939;DP=1707;AF=0.49;MQM=60	CIZ1	missense	CIZ1:ENST00000277465:missense_variant:MODERATE:exon11/17:c.1828G>A:p.Val610Met:,CIZ1:ENST00000325721:missense_variant:MODERATE:exon10/16:c.1825G>A:p.Val609Met:,CIZ1:ENST00000357558:missense_variant:MODERATE:exon12/18:c.1828G>A:p.Val610Met:,CIZ1:ENST00000372938:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:,CIZ1:ENST00000372948:missense_variant:MODERATE:exon12/18:c.1744G>A:p.Val582Met:,CIZ1:ENST00000372954:missense_variant:MODERATE:exon11/17:c.1672G>A:p.Val558Met:,CIZ1:ENST00000393608:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:,CIZ1:ENST00000538431:missense_variant:MODERATE:exon11/18:c.1912G>A:p.Val638Met:,CIZ1:ENST00000541172:missense_variant:MODERATE:exon10/16:c.1609G>A:p.Val537Met:						rs11549266	0.0545	0.0980	201,.	0.0197,0.0493,0.0004,0.1385,0.0719	0.6690	T(0.62),T(0.63),T(0.62),T(0.60),T(0.64),T(0.67),T(0.60),T(0.59),T(0.59)	B(0.01),B(0.14),B(0.01),B(0.01),B(0.01),B(0.04),B(0.01),B(0.01),B(0.01)	0.17,0.52	5.75	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130939707	130939707	A	T	hom		QUAL=11151;DP=374;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465:intron_variant:MODIFIER:exon10/16:c.1734+138T>A::,CIZ1:ENST00000325721:intron_variant:MODIFIER:exon9/15:c.1731+138T>A::,CIZ1:ENST00000357558:intron_variant:MODIFIER:exon11/17:c.1734+138T>A::,CIZ1:ENST00000372938:intron_variant:MODIFIER:exon10/16:c.1818+138T>A::,CIZ1:ENST00000372948:intron_variant:MODIFIER:exon11/17:c.1650+138T>A::,CIZ1:ENST00000372954:intron_variant:MODIFIER:exon10/16:c.1578+138T>A::,CIZ1:ENST00000393608:intron_variant:MODIFIER:exon10/16:c.1818+138T>A::,CIZ1:ENST00000538431:intron_variant:MODIFIER:exon10/17:c.1818+138T>A::,CIZ1:ENST00000541172:intron_variant:MODIFIER:exon9/15:c.1515+138T>A::	regulatory_region_variant:promoter_flanking_region					rs4240426		0.9897	15382,.		-0.1220			0.00,0.09	5.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130940121	130940121	G	A	hom		QUAL=19004;DP=669;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465:intron_variant:MODIFIER:exon9/16:c.1537-79C>T::,CIZ1:ENST00000325721:intron_variant:MODIFIER:exon8/15:c.1534-79C>T::,CIZ1:ENST00000357558:intron_variant:MODIFIER:exon10/17:c.1537-79C>T::,CIZ1:ENST00000372938:intron_variant:MODIFIER:exon9/16:c.1621-79C>T::,CIZ1:ENST00000372948:intron_variant:MODIFIER:exon10/17:c.1453-79C>T::,CIZ1:ENST00000372954:intron_variant:MODIFIER:exon9/16:c.1381-79C>T::,CIZ1:ENST00000393608:intron_variant:MODIFIER:exon9/16:c.1621-79C>T::,CIZ1:ENST00000538431:intron_variant:MODIFIER:exon9/17:c.1621-79C>T::,CIZ1:ENST00000541172:intron_variant:MODIFIER:exon8/15:c.1318-79C>T::	regulatory_region_variant:promoter_flanking_region					rs4075428		0.7124	8130,.		-1.0590			0.01,0.09	3.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130940822	130940822	C	T	hom		QUAL=6706;DP=247;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465:intron_variant:MODIFIER:exon8/16:c.1415-53G>A::,CIZ1:ENST00000325721:intron_variant:MODIFIER:exon7/15:c.1412-53G>A::,CIZ1:ENST00000357558:intron_variant:MODIFIER:exon9/17:c.1415-53G>A::,CIZ1:ENST00000372938:intron_variant:MODIFIER:exon8/16:c.1499-53G>A::,CIZ1:ENST00000372948:intron_variant:MODIFIER:exon9/17:c.1331-53G>A::,CIZ1:ENST00000372954:intron_variant:MODIFIER:exon8/16:c.1259-53G>A::,CIZ1:ENST00000393608:intron_variant:MODIFIER:exon8/16:c.1499-53G>A::,CIZ1:ENST00000538431:intron_variant:MODIFIER:exon8/17:c.1499-53G>A::,CIZ1:ENST00000541172:intron_variant:MODIFIER:exon7/15:c.1196-53G>A::						rs3892074	0.6873	0.6026	5908,.		0.0990			0.21,0.25	1.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	130942972	130942972	T	C	hom		QUAL=4848;DP=178;AF=0.97;MQM=60	CIZ1	intron	CIZ1:ENST00000277465:intron_variant:MODIFIER:exon5/16:c.682+28A>G::,CIZ1:ENST00000325721:intron_variant:MODIFIER:exon5/15:c.595+28A>G::,CIZ1:ENST00000357558:intron_variant:MODIFIER:exon6/17:c.682+28A>G::,CIZ1:ENST00000372938:intron_variant:MODIFIER:exon6/16:c.682+28A>G::,CIZ1:ENST00000372948:intron_variant:MODIFIER:exon6/17:c.682+28A>G::,CIZ1:ENST00000372954:intron_variant:MODIFIER:exon5/16:c.610+28A>G::,CIZ1:ENST00000393608:intron_variant:MODIFIER:exon6/16:c.682+28A>G::,CIZ1:ENST00000538431:intron_variant:MODIFIER:exon6/17:c.682+28A>G::,CIZ1:ENST00000541172:intron_variant:MODIFIER:exon5/15:c.379+28A>G::						rs45585631	0.6927	0.6917	6105,.	0.4549,0.8066,0.9537,0.6528,0.7540	0.1480			0.05,0.15	5.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)
chr9	132576512	132576512	G	T	het		QUAL=13781;DP=1098;AF=0.49;MQM=60	TOR1A	intron	TOR1A:ENST00000351698:intron_variant:MODIFIER:exon4/4:c.749-11C>A::		605204 [GENE=TOR1A PHENOS=Dystonia-1,modifier of/Dystonia-1,torsion,128100,Autosomal dominant];	255137 [benign/likely benign DISEASE=Dystonia 1,not specified];			rs72755217	0.0166	0.0206	0,.	0.0038,0.0135,0.0002,0.0162,0.0649	0.1370			0.15,0.23	3.41		11.65>9.82		0.000/0.022		10	447	0 / 27					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56)
chr9	132586005	132586005	G	C	het		QUAL=380;DP=52;AF=0.77;MQM=59	TOR1A	intron	TOR1A:ENST00000351698:intron_variant:MODIFIER:exon1/4:c.178+182C>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,modifier of/Dystonia-1,torsion,128100,Autosomal dominant];			(CCCCAG)n (Simple_repeat)						-1.0020			0.01,0.06	3.33						0	34	0 / 0					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56)
chr9	132586046	132586046	T	C	het		QUAL=10;DP=24;AF=0.58;MQM=60	TOR1A	intron	TOR1A:ENST00000351698:intron_variant:MODIFIER:exon1/4:c.178+141A>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,modifier of/Dystonia-1,torsion,128100,Autosomal dominant];			(CCCCAG)n (Simple_repeat)						0.0580			0.01,0.07	4.96						0	17	0 / 0					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56)
chr9	132586054	132586054	T	C	het		QUAL=29;DP=10;AF=0.70;MQM=60	TOR1A	intron	TOR1A:ENST00000351698:intron_variant:MODIFIER:exon1/4:c.178+133A>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,modifier of/Dystonia-1,torsion,128100,Autosomal dominant];			(CCCCAG)n (Simple_repeat)	rs1422922344					-1.4120			0.00,0.04	3.65						1	25	0 / 0					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56)
chr9	132586416	132586416	A	C	het		QUAL=8873;DP=703;AF=0.53;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	605204 [GENE=TOR1A PHENOS=Dystonia-1,modifier of/Dystonia-1,torsion,128100,Autosomal dominant];	365238 [likely benign DISEASE=Dystonia 1];			rs114150156	0.0723	0.0568	125,.	0.1808,0.0224,0.0002,0.0163,0.0670	-4.3930			0.00,1.00	3.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9orf78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)
chr9	132586485	132586485	C	T	het		QUAL=27;DP=15;AF=0.27;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant										-0.1920			0.00,1.00	8.76						108	34	0 / 0	2	[2] auto-classification 08.11.2017  			TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9orf78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)
chr9	132586552	132586552	T	A	het		QUAL=355;DP=36;AF=0.67;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs72755223	0.0721	0.0569	126,.		-2.6860			0.00,1.00	7.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9orf78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)
chr9	135139901	135139901	T	C	het		QUAL=13369;DP=1131;AF=0.49;MQM=60	SETX	missense	SETX:ENST00000224140:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:,SETX:ENST00000372169:missense_variant:MODERATE:exon27/27:c.7846A>G:p.Ile2616Val:,SETX:ENST00000393220:missense_variant:MODERATE:exon25/25:c.7660A>G:p.Ile2554Val:		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	95669 [benign DISEASE=not specified,Amyotrophic Lateral Sclerosis, Dominant,Ataxia with Oculomotor Apraxia,not provided];			rs1056899	0.5387	0.4449	3790,.	0.7561,0.3160,0.7274,0.2953,0.4408	-1.1110	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.02,0.13	0.02	0.19				COSM3763694,COSM3763695	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135153668	135153668	C	T	het		QUAL=10409;DP=832;AF=0.47;MQM=60	SETX	intron	SETX:ENST00000224140:intron_variant:MODIFIER:exon20/25:c.6655-24G>A::,SETX:ENST00000372169:intron_variant:MODIFIER:exon20/26:c.6655-24G>A::,SETX:ENST00000393220:intron_variant:MODIFIER:exon20/24:c.6655-24G>A::		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	260513 [benign DISEASE=not specified];			rs11243704	0.5339	0.4423	3730,.	0.7549,0.2890,0.7152,0.2944,0.4399	-1.0590			0.01,0.08	1.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135153673	135153673	T	C	het	off-target	QUAL=9708;DP=832;AF=0.47;MQM=60	SETX	intron	SETX:ENST00000224140:intron_variant:MODIFIER:exon20/25:c.6655-29A>G::,SETX:ENST00000372169:intron_variant:MODIFIER:exon20/26:c.6655-29A>G::,SETX:ENST00000393220:intron_variant:MODIFIER:exon20/24:c.6655-29A>G::		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];				rs11243705	0.1587	0.1649	334,.	0.0976,0.1440,0.2905,0.1651,0.1575	0.4200			0.03,0.13	6.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135202829	135202829	T	C	hom		QUAL=10686;DP=416;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:,SETX:ENST00000372169:missense_variant:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val:,SETX:ENST00000393220:missense_variant:MODERATE:exon10/25:c.4156A>G:p.Ile1386Val:		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	95663 [benign DISEASE=not specified,Amyotrophic Lateral Sclerosis, Dominant,Ataxia with Oculomotor Apraxia,not provided];			rs543573		0.7345	8039,.	0.3739,0.7950,0.3052,0.8417,0.6352	-0.6580	T(0.55),T(0.56),T(0.55)	B(0.00),B(0.00),B(0.00)	0.06,0.18	0.01	0.25				COSM3982759	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135203231	135203231	C	T	hom		QUAL=2641;DP=85;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000372169:missense_variant:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000393220:missense_variant:MODERATE:exon10/25:c.3754G>A:p.Gly1252Arg:		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	95662 [benign DISEASE=not specified,Amyotrophic Lateral Sclerosis, Dominant,Ataxia with Oculomotor Apraxia,not provided];			rs1183768	0.5561	0.7344	8030,.	0.3738,0.7949,0.3050,0.8417,0.6352	0.4900	T(0.43),T(0.43),T(0.43)	B(0.11),B(0.22),B(0.22)	0.22,0.86	18.97	0.24				COSM3982760	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135203409	135203409	A	C	hom		QUAL=2750;DP=88;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000372169:missense_variant:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000393220:missense_variant:MODERATE:exon10/25:c.3576T>G:p.Asp1192Glu:		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	95661 [benign DISEASE=not specified,Amyotrophic Lateral Sclerosis, Dominant,Ataxia with Oculomotor Apraxia,not provided];			rs1185193		0.7679	9525,.	0.6419,0.8121,0.3127,0.8566,0.6539	-0.9940	T(0.42),T(0.41),T(0.41)	B(0.00),B(0.01),B(0.01)	0.09,0.19	0.01	0.27					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135206460	135206460	A	G	hom		QUAL=3359;DP=100;AF=1.00;MQM=60	SETX	synonymous	SETX:ENST00000224140:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:,SETX:ENST00000372169:synonymous_variant:LOW:exon9/27:c.1077T>C:p.Tyr359=:,SETX:ENST00000393220:synonymous_variant:LOW:exon9/25:c.1077T>C:p.Tyr359=:		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];	95658 [benign DISEASE=not specified,Amyotrophic Lateral Sclerosis, Dominant,Ataxia with Oculomotor Apraxia,not provided];			rs9411449	0.6266	0.7524	9101,.	0.6171,0.8059,0.3075,0.8422,0.6361	0.1510			0.20,0.41	6.35					COSM4163458	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135211610	135211611	AC	-	hom	off-target	QUAL=11391;DP=387;AF=1.00;MQM=60	SETX	intron	SETX:ENST00000224140:intron_variant:MODIFIER:exon6/25:c.718+72_718+73del::,SETX:ENST00000372169:intron_variant:MODIFIER:exon6/26:c.718+72_718+73del::,SETX:ENST00000393220:intron_variant:MODIFIER:exon6/24:c.718+72_718+73del::		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];			AluSz (SINE/Alu)	rs111938515	0.6146	0.7374	8793,.		0.4810				4.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135221597	135221597	G	A	hom	off-target	QUAL=12692;DP=403;AF=1.00;MQM=60	SETX	intron	SETX:ENST00000224140:intron_variant:MODIFIER:exon4/25:c.388+51C>T::,SETX:ENST00000372169:intron_variant:MODIFIER:exon4/26:c.388+51C>T::,SETX:ENST00000393220:intron_variant:MODIFIER:exon4/24:c.388+51C>T::		608465 [GENE=SETX PHENOS=Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant/Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive];				rs497650	0.9956	0.9991	15570,.	0.9867,0.9994,1.0000,1.0000,1.0000	0.3960			0.00,0.07	1.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	140777306	140777306	C	G	het		QUAL=7266;DP=2538;AF=0.21;MQM=60	CACNA1B,RP11-188C12.3	5'UTR,missense,non_coding_transcript_exon	CACNA1B:ENST00000277549:5_prime_UTR_variant:MODIFIER:exon3/47:c.-1924C>G::,CACNA1B:ENST00000277551:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520,CACNA1B:ENST00000371355:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520,CACNA1B:ENST00000371357:missense_variant:MODERATE:exon3/46:c.501C>G:p.Asn167Lys:PF00520,CACNA1B:ENST00000371363:missense_variant:MODERATE:exon3/46:c.501C>G:p.Asn167Lys:PF00520,CACNA1B:ENST00000371372:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520,RP11-188C12.3:ENST00000371390:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2674G>C::						rs4422842		0.5000	0,.	0.5000,0.5000,0.4993,0.5000,0.5000	-1.1760	 ,D(0.01),D(0.01),D(0.01),D(0.01),D(0.01), 	 ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00), 	0.11,0.93	14.85	0.75				COSM4007112	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16), RP11-188C12.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr9	140777370	140777370	A	C	hom	off-target	QUAL=86551;DP=2982;AF=1.00;MQM=60	CACNA1B,RP11-188C12.3	intron,non_coding_transcript_exon	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon3/46:c.-1895+35A>C::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon3/46:c.530+35A>C::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon3/46:c.530+35A>C::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon3/45:c.530+35A>C::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon3/45:c.530+35A>C::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon3/46:c.530+35A>C::,RP11-188C12.3:ENST00000371390:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2610T>G::						rs1110146		0.5927	2907,.	0.7046,0.5450,0.5227,0.5468,0.5441	-1.5520			0.00,0.19	6.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16), RP11-188C12.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr9	140881314	140881314	A	C	het		QUAL=31981;DP=3294;AF=0.40;MQM=60	CACNA1B	splice_region&intron	CACNA1B:ENST00000277549:splice_region_variant&intron_variant:LOW:exon15/46:c.-451+8A>C::,CACNA1B:ENST00000277551:splice_region_variant&intron_variant:LOW:exon15/46:c.1974+8A>C::,CACNA1B:ENST00000371355:splice_region_variant&intron_variant:LOW:exon15/46:c.1977+8A>C::,CACNA1B:ENST00000371357:splice_region_variant&intron_variant:LOW:exon15/45:c.1977+8A>C::,CACNA1B:ENST00000371363:splice_region_variant&intron_variant:LOW:exon15/45:c.1974+8A>C::,CACNA1B:ENST00000371372:splice_region_variant&intron_variant:LOW:exon15/46:c.1974+8A>C::						rs7034745	0.4215	0.3136	2099,.	0.5786,0.1323,0.6597,0.1897,0.3427	-1.4060			0.01,0.17	0.50				0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140901146	140901146	A	G	het	off-target	QUAL=6212;DP=654;AF=0.49;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon15/46:c.-450-73A>G::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon15/46:c.1975-73A>G::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon15/46:c.1978-73A>G::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon15/45:c.1978-73A>G::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon15/45:c.1975-73A>G::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon15/46:c.1975-73A>G::						rs2290580	0.4293	0.3210	2497,.		-3.2510			0.00,0.05	0.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140911670	140911670	C	T	het		QUAL=13342;DP=1435;AF=0.38;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon18/46:c.-158+3983C>T::,CACNA1B:ENST00000277550:intron_variant:MODIFIER:exon3/3:c.203+17C>T::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon18/46:c.2267+3983C>T::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon18/46:c.2270+3983C>T::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon18/45:c.2270+3983C>T::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon18/45:c.2267+3983C>T::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon18/46:c.2267+3983C>T::						rs7028989	0.3968	0.2939	1969,.	0.5796,0.1186,0.6368,0.1568,0.2815	-0.0080			0.10,0.95	12.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140917779	140917779	G	T	het		QUAL=20532;DP=1953;AF=0.48;MQM=60	CACNA1B	missense	CACNA1B:ENST00000277549:missense_variant:MODERATE:exon19/47:c.160G>T:p.Ala54Ser:,CACNA1B:ENST00000277551:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:,CACNA1B:ENST00000371355:missense_variant:MODERATE:exon19/47:c.2587G>T:p.Ala863Ser:,CACNA1B:ENST00000371357:missense_variant:MODERATE:exon19/46:c.2587G>T:p.Ala863Ser:,CACNA1B:ENST00000371363:missense_variant:MODERATE:exon19/46:c.2584G>T:p.Ala862Ser:,CACNA1B:ENST00000371372:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter					rs7873074	0.4269	0.3194	2460,.	0.6658,0.1239,0.6544,0.1626,0.2764	-0.1580	T(0.69),T(0.71),T(0.74),T(0.74),T(0.75),T(0.74)	B(0.14),B(0.07),B(0.17),B(0.08),B(0.08),B(0.08)	0.15,0.38	9.11	0.32				COSM4163656,COSM4163657	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140918171	140918185	GGAGAAGGAGACCAC	-	het		QUAL=12441;DP=1069;AF=0.59;MQM=60	CACNA1B	inframe_deletion,5'UTR	CACNA1B:ENST00000277549:inframe_deletion:MODERATE:exon19/47:c.562_576del:p.Thr188_Glu192del:,CACNA1B:ENST00000277551:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:,CACNA1B:ENST00000371355:inframe_deletion:MODERATE:exon19/47:c.2989_3003del:p.Thr997_Glu1001del:,CACNA1B:ENST00000371357:inframe_deletion:MODERATE:exon19/46:c.2989_3003del:p.Thr997_Glu1001del:,CACNA1B:ENST00000371363:inframe_deletion:MODERATE:exon19/46:c.2986_3000del:p.Thr996_Glu1000del:,CACNA1B:ENST00000371367:5_prime_UTR_variant:MODIFIER:exon1/3:c.-63_-49del::,CACNA1B:ENST00000371372:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:	regulatory_region_variant:promoter				GA-rich (Low_complexity)	rs145816559	0.3974	0.2924	1837,.	0.5394,0.1188,0.6306,0.1544,0.2770	5.0290				11.15					COSM4187258,COSM455673,COSM5826494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140918300	140918300	G	C	het	off-target	QUAL=7660;DP=786;AF=0.45;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon19/46:c.644+37G>C::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon19/46:c.3068+37G>C::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon19/46:c.3071+37G>C::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon19/45:c.3071+37G>C::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon19/45:c.3068+37G>C::,CACNA1B:ENST00000371367:intron_variant:MODIFIER:exon1/2:c.20+37G>C::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon19/46:c.3068+37G>C::,CACNA1B:ENST00000545473:intron_variant:MODIFIER:exon1/6:c.20+37G>C::	regulatory_region_variant:promoter				G-rich (Low_complexity)	rs6559259	0.3864	0.2846	1788,.	0.5327,0.1197,0.6323,0.1582,0.2787	0.7450			0.08,0.21	5.91			loss/donor/140918300-140918301/Medium/0.554439			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140938183	140938183	A	G	het	off-target	QUAL=1921;DP=172;AF=0.52;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon20/46:c.863-43A>G::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon20/46:c.3287-43A>G::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon20/46:c.3290-43A>G::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon20/45:c.3290-43A>G::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon20/45:c.3287-43A>G::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon20/46:c.3287-43A>G::,CACNA1B:ENST00000545473:intron_variant:MODIFIER:exon3/6:c.365-43A>G::						rs3750506	0.4577	0.3482	2634,.	0.6505,0.1451,0.6638,0.2012,0.3570	-4.1830			0.00,0.06	0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	140946701	140946701	-	GTGTGTGCGTGTGT	het	off-target	QUAL=177;DP=221;AF=0.22;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon26/46:c.1395+68_1395+69insCGTGTGTGTGTGTG::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon25/46:c.3807+68_3807+69insCGTGTGTGTGTGTG::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon25/46:c.3810+68_3810+69insCGTGTGTGTGTGTG::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon25/45:c.3810+68_3810+69insCGTGTGTGTGTGTG::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon25/45:c.3807+68_3807+69insCGTGTGTGTGTGTG::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon25/46:c.3807+68_3807+69insCGTGTGTGTGTGTG::					(TG)n (Simple_repeat)	rs140068697		0.3434	2359,.						0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	141008876	141008876	C	T	het		QUAL=35384;DP=2955;AF=0.44;MQM=60	CACNA1B	synonymous	CACNA1B:ENST00000277549:synonymous_variant:LOW:exon41/47:c.3165C>T:p.Phe1055=:PF08763,CACNA1B:ENST00000277551:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:PF08763,CACNA1B:ENST00000371355:synonymous_variant:LOW:exon41/47:c.5586C>T:p.Phe1862=:PF08763,CACNA1B:ENST00000371357:synonymous_variant:LOW:exon40/46:c.5580C>T:p.Phe1860=:PF08763,CACNA1B:ENST00000371363:synonymous_variant:LOW:exon40/46:c.5577C>T:p.Phe1859=:PF08763,CACNA1B:ENST00000371372:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:PF08763						rs2229948	0.5046	0.6808	6684,.	0.3022,0.7197,0.2710,0.7522,0.6797	-1.1370			0.08,0.96	7.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	141015019	141015019	G	C	het	off-target	QUAL=4554;DP=411;AF=0.51;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon45/46:c.3821-64G>C::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon45/46:c.6239-64G>C::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon45/46:c.6242-64G>C::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon44/45:c.6236-64G>C::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon44/45:c.6233-64G>C::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon45/46:c.6239-64G>C::						rs2278971	0.2674	0.2962	1528,.		-0.8510			0.01,0.08	0.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	141015351	141015351	A	G	het		QUAL=8129;DP=1046;AF=0.39;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon46/46:c.4071+18A>G::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon46/46:c.6489+18A>G::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon46/46:c.6492+18A>G::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon45/45:c.6486+18A>G::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon45/45:c.6483+18A>G::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon46/46:c.6489+18A>G::						rs2278972	0.2726	0.3277	1572,.	0.2021,0.2272,0.3063,0.3823,0.3182	-1.8790			0.00,0.10	4.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	141015869	141015869	C	T	hom	off-target	QUAL=1507;DP=712;AF=0.17;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549:intron_variant:MODIFIER:exon46/46:c.4072-52C>T::,CACNA1B:ENST00000277551:intron_variant:MODIFIER:exon46/46:c.6490-239C>T::,CACNA1B:ENST00000371355:intron_variant:MODIFIER:exon46/46:c.6493-52C>T::,CACNA1B:ENST00000371357:intron_variant:MODIFIER:exon45/45:c.6487-52C>T::,CACNA1B:ENST00000371363:intron_variant:MODIFIER:exon45/45:c.6484-52C>T::,CACNA1B:ENST00000371372:intron_variant:MODIFIER:exon46/46:c.6490-52C>T::						rs966241485					-0.1780			0.04,0.44	2.84						15	0	0 / 0					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr9	141016262	141016262	T	G	hom		QUAL=40988;DP=1388;AF=1.00;MQM=60	CACNA1B	synonymous,missense	CACNA1B:ENST00000277549:synonymous_variant:LOW:exon47/47:c.4413T>G:p.Thr1471=:,CACNA1B:ENST00000277551:missense_variant:MODERATE:exon47/47:c.6644T>G:p.Leu2215Arg:,CACNA1B:ENST00000371355:synonymous_variant:LOW:exon47/47:c.6834T>G:p.Thr2278=:,CACNA1B:ENST00000371357:synonymous_variant:LOW:exon46/46:c.6828T>G:p.Thr2276=:,CACNA1B:ENST00000371363:synonymous_variant:LOW:exon46/46:c.6825T>G:p.Thr2275=:,CACNA1B:ENST00000371372:synonymous_variant:LOW:exon47/47:c.6831T>G:p.Thr2277=:						rs2278973		0.9132	13100,.	0.9618,0.8791,0.7942,0.9013,0.9272	-0.6660	 ,T(0.46), , , , 	 , (0.00), , , , 	0.01,0.20	2.30	0.22				COSM3763836	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AD oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)
chr10	78729669	78729669	A	G	het	off-target	QUAL=8138;DP=753;AF=0.44;MQM=60	KCNMA1,RP11-443A13.5	intron,intron&non_coding_transcript	KCNMA1:ENST00000286627:intron_variant:MODIFIER:exon19/26:c.2186+63T>C::,KCNMA1:ENST00000286628:intron_variant:MODIFIER:exon20/27:c.2360+63T>C::,KCNMA1:ENST00000354353:intron_variant:MODIFIER:exon21/28:c.2369+63T>C::,KCNMA1:ENST00000372440:intron_variant:MODIFIER:exon19/27:c.2186+63T>C::,KCNMA1:ENST00000372443:intron_variant:MODIFIER:exon19/28:c.2186+63T>C::,KCNMA1:ENST00000404771:intron_variant:MODIFIER:exon20/29:c.2360+63T>C::,KCNMA1:ENST00000404857:intron_variant:MODIFIER:exon19/27:c.2186+63T>C::,KCNMA1:ENST00000406533:intron_variant:MODIFIER:exon21/28:c.2372+63T>C::,RP11-443A13.5:ENST00000458661:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.426-7699A>G::,RP11-443A13.5:ENST00000598613:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.677-7699A>G::,RP11-443A13.5:ENST00000600782:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/4:n.312-5370A>G::	regulatory_region_variant:enhancer	600150 [GENE=KCNMA1 PHENOS=Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];			G-rich (Low_complexity)	rs2288837	0.8558	0.8314	10868,.		-0.2220			0.01,0.13	13.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16), RP11-443A13.5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	78778734	78778734	G	A	het	off-target	QUAL=2003;DP=235;AF=0.48;MQM=60	KCNMA1	intron	KCNMA1:ENST00000286627:intron_variant:MODIFIER:exon17/26:c.2015+37C>T::,KCNMA1:ENST00000286628:intron_variant:MODIFIER:exon17/27:c.2015+37C>T::,KCNMA1:ENST00000354353:intron_variant:MODIFIER:exon17/28:c.2015+37C>T::,KCNMA1:ENST00000372440:intron_variant:MODIFIER:exon17/27:c.2015+37C>T::,KCNMA1:ENST00000372443:intron_variant:MODIFIER:exon17/28:c.2015+37C>T::,KCNMA1:ENST00000404771:intron_variant:MODIFIER:exon17/29:c.2015+37C>T::,KCNMA1:ENST00000404857:intron_variant:MODIFIER:exon17/27:c.2015+37C>T::,KCNMA1:ENST00000406533:intron_variant:MODIFIER:exon18/28:c.2027+37C>T::		600150 [GENE=KCNMA1 PHENOS=Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];				rs16934182	0.3722	0.5474	5231,.	0.3595,0.4485,0.0068,0.6725,0.4841	0.5290			0.01,0.27	3.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)
chr10	78868166	78868168	AAA	-	het	off-target	QUAL=2117;DP=369;AF=0.33;MQM=60	KCNMA1	intron	KCNMA1:ENST00000286627:intron_variant:MODIFIER:exon9/26:c.1223+71_1223+73del::,KCNMA1:ENST00000286628:intron_variant:MODIFIER:exon9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000354353:intron_variant:MODIFIER:exon9/28:c.1223+71_1223+73del::,KCNMA1:ENST00000372440:intron_variant:MODIFIER:exon9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000372443:intron_variant:MODIFIER:exon9/28:c.1223+71_1223+73del::,KCNMA1:ENST00000404771:intron_variant:MODIFIER:exon9/29:c.1223+71_1223+73del::,KCNMA1:ENST00000404857:intron_variant:MODIFIER:exon9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000406533:intron_variant:MODIFIER:exon9/28:c.1223+71_1223+73del::	regulatory_region_variant:promoter_flanking_region	600150 [GENE=KCNMA1 PHENOS=Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];			A-rich (Low_complexity)	rs138226779		0.8505	10027,.		4.6620				19.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)
chr10	78944590	78944590	G	A	het		QUAL=37;DP=99;AF=0.16;MQM=60	KCNMA1	synonymous	KCNMA1:ENST00000286627:synonymous_variant:LOW:exon4/27:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000286628:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000354353:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000372440:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000372443:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000404771:synonymous_variant:LOW:exon4/30:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000404857:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520,KCNMA1:ENST00000406533:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520		600150 [GENE=KCNMA1 PHENOS=Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];	129328 [benign/likely benign DISEASE=Generalized epilepsy and paroxysmal dyskinesia,not specified,not provided];			rs1131824	0.4059	0.4121	3020,.	0.6370,0.2066,0.2667,0.3591,0.3254	1.4100			0.29,0.97	12.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)
chr11	2186335	2186335	A	G	het		QUAL=3984;DP=385;AF=0.44;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon10/10:c.1064+127T>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon12/12:c.1334+127T>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon13/13:c.1415+127T>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon13/13:c.1427+127T>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];		CS088007 [CLASS=DFP MUT=ALT PHEN="Hypertension association with" GENE=TH];		rs2070762	0.4235	0.4232	3050,.		-0.2170			0.02,0.10	1.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187071	2187071	T	C	hom		QUAL=74629;DP=2461;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon8/10:c.835-78A>G::,TH:ENST00000352909:intron_variant:MODIFIER:exon10/12:c.1105-78A>G::,TH:ENST00000381175:intron_variant:MODIFIER:exon11/13:c.1186-78A>G::,TH:ENST00000381178:intron_variant:MODIFIER:exon11/13:c.1198-78A>G::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs6578990	0.9117	0.9141	13346,.		-0.8480			0.00,0.08	6.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187398	2187398	T	G	hom		QUAL=40330;DP=1369;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon7/10:c.778-110A>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon9/12:c.1048-110A>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon10/13:c.1129-110A>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon10/13:c.1141-110A>C::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072823		0.9182	13460,.		-3.9320			0.00,0.08	0.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187439	2187439	C	A	het		QUAL=85;DP=19;AF=0.42;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon7/10:c.778-151G>T::,TH:ENST00000352909:intron_variant:MODIFIER:exon9/12:c.1048-151G>T::,TH:ENST00000381175:intron_variant:MODIFIER:exon10/13:c.1129-151G>T::,TH:ENST00000381178:intron_variant:MODIFIER:exon10/13:c.1141-151G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072824	0.7342	0.6518	6818,.		-1.4820			0.01,0.18	3.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187455	2187455	T	G	het		QUAL=184;DP=24;AF=0.50;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon7/10:c.778-167A>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon9/12:c.1048-167A>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon10/13:c.1129-167A>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon10/13:c.1141-167A>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7479936		0.6049	6191,.		0.2950			0.01,0.12	5.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187477	2187477	C	T	hom		QUAL=505;DP=24;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon7/10:c.778-189G>A::,TH:ENST00000352909:intron_variant:MODIFIER:exon9/12:c.1048-189G>A::,TH:ENST00000381175:intron_variant:MODIFIER:exon10/13:c.1129-189G>A::,TH:ENST00000381178:intron_variant:MODIFIER:exon10/13:c.1141-189G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7483805		0.9177	13433,.		-1.4920			0.00,0.09	2.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187482	2187482	C	G	het		QUAL=184;DP=24;AF=0.50;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon7/10:c.778-194G>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon9/12:c.1048-194G>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon10/13:c.1129-194G>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon10/13:c.1141-194G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072826		0.6041	6193,.		-0.9040			0.01,0.14	2.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2187855	2187855	G	C	het		QUAL=1922;DP=200;AF=0.45;MQM=60	TH	intron,splice_region&intron	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.708-76C>G::,TH:ENST00000352909:splice_region_variant&intron_variant:LOW:exon8/12:c.977+8C>G::,TH:ENST00000381175:splice_region_variant&intron_variant:LOW:exon9/13:c.1058+8C>G::,TH:ENST00000381178:splice_region_variant&intron_variant:LOW:exon9/13:c.1070+8C>G::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263250 [benign DISEASE=Segawa syndrome, autosomal recessive,not specified,not provided];			rs12419447	0.1799	0.2787	1378,.	0.1327,0.2344,0.0376,0.3713,0.1664	0.1750			0.03,0.20	11.31				0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2188238	2188238	C	T	het		QUAL=6620;DP=537;AF=0.51;MQM=60	TH	intron,synonymous	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.707+427G>A::,TH:ENST00000352909:synonymous_variant:LOW:exon7/13:c.720G>A:p.Lys240=:PF00351,TH:ENST00000381175:synonymous_variant:LOW:exon8/14:c.801G>A:p.Lys267=:PF00351,TH:ENST00000381178:synonymous_variant:LOW:exon8/14:c.813G>A:p.Lys271=:PF00351		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263258 [benign DISEASE=Segawa syndrome, autosomal recessive,not specified,not provided];			rs6357	0.1546	0.2410	1085,.	0.1235,0.1627,0.0351,0.3098,0.1399	0.9300			0.41,0.97	12.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2188388	2188388	G	C	hom		QUAL=193;DP=8;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.707+277C>G::,TH:ENST00000352909:intron_variant:MODIFIER:exon6/12:c.696-126C>G::,TH:ENST00000381175:intron_variant:MODIFIER:exon7/13:c.777-126C>G::,TH:ENST00000381178:intron_variant:MODIFIER:exon7/13:c.789-126C>G::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7942881	0.9155	0.9177	13467,.		1.1780			0.06,0.18	6.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2188400	2188400	C	T	hom		QUAL=189;DP=8;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.707+265G>A::,TH:ENST00000352909:intron_variant:MODIFIER:exon6/12:c.696-138G>A::,TH:ENST00000381175:intron_variant:MODIFIER:exon7/13:c.777-138G>A::,TH:ENST00000381178:intron_variant:MODIFIER:exon7/13:c.789-138G>A::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925784		0.9178	13465,.		-0.7510			0.00,0.03	2.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2188436	2188436	A	G	het		QUAL=29;DP=8;AF=0.38;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.707+229T>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon6/12:c.696-174T>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon7/13:c.777-174T>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon7/13:c.789-174T>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs67482701	0.1627	0.2485	1151,.		-0.1350			0.01,0.09	3.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2188566	2188566	C	T	hom		QUAL=1395;DP=62;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon6/10:c.707+99G>A::,TH:ENST00000352909:intron_variant:MODIFIER:exon6/12:c.695+99G>A::,TH:ENST00000381175:intron_variant:MODIFIER:exon7/13:c.776+99G>A::,TH:ENST00000381178:intron_variant:MODIFIER:exon7/13:c.788+99G>A::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925924	0.9155	0.9178	13470,.		0.3620			0.02,0.11	4.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2189185	2189185	G	A	het		QUAL=17306;DP=1313;AF=0.52;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon4/10:c.589-22C>T::,TH:ENST00000352909:intron_variant:MODIFIER:exon4/12:c.577-22C>T::,TH:ENST00000381175:intron_variant:MODIFIER:exon5/13:c.658-22C>T::,TH:ENST00000381178:intron_variant:MODIFIER:exon5/13:c.670-22C>T::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263257 [benign DISEASE=not specified];			rs4074905	0.7057	0.7209	6518,.	0.4500,0.7767,0.9625,0.6692,0.8508	-0.0730			0.00,0.10	1.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2189954	2189954	A	G	het		QUAL=2589;DP=1475;AF=0.25;MQM=58	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon2/10:c.325-59T>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon2/12:c.313-59T>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon3/13:c.394-59T>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon3/13:c.406-59T>C::	regulatory_region_variant:enhancer	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];			GA-rich (Low_complexity)	rs1301918657		0.0113	0,.		-2.6810			0.01,0.12	2.27						0	123	0 / 0					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2189958	2189958	T	G	het		QUAL=2589;DP=1475;AF=0.25;MQM=58	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon2/10:c.325-63A>C::,TH:ENST00000352909:intron_variant:MODIFIER:exon2/12:c.313-63A>C::,TH:ENST00000381175:intron_variant:MODIFIER:exon3/13:c.394-63A>C::,TH:ENST00000381178:intron_variant:MODIFIER:exon3/13:c.406-63A>C::	regulatory_region_variant:enhancer	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs1024599262		0.0377	0,.		-2.5170			0.00,0.08	0.15			loss/donor/2189957-2189958/Medium/2.373778			0	128	0 / 0					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2189983	2189983	C	T	het		QUAL=23522;DP=1842;AF=0.52;MQM=59	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon2/10:c.325-88G>A::,TH:ENST00000352909:intron_variant:MODIFIER:exon2/12:c.313-88G>A::,TH:ENST00000381175:intron_variant:MODIFIER:exon3/13:c.394-88G>A::,TH:ENST00000381178:intron_variant:MODIFIER:exon3/13:c.406-88G>A::	regulatory_region_variant:enhancer	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4930043	0.1430	0.2287	1005,.		0.9010			0.11,0.22	7.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2190951	2190951	C	T	het		QUAL=9625;DP=753;AF=0.50;MQM=60	TH	missense	TH:ENST00000333684:missense_variant:MODERATE:exon2/11:c.253G>A:p.Val85Met:,TH:ENST00000352909:missense_variant:MODERATE:exon2/13:c.241G>A:p.Val81Met:,TH:ENST00000381175:missense_variant:MODERATE:exon3/14:c.322G>A:p.Val108Met:,TH:ENST00000381178:missense_variant:MODERATE:exon3/14:c.334G>A:p.Val112Met:	regulatory_region_variant:enhancer	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	21866 [benign DISEASE=Segawa syndrome, autosomal recessive,not specified,not provided];			rs6356	0.4305	0.4286	2153,.	0.1322,0.4351,0.7989,0.3724,0.5581	-0.3270	T(0.26),T(0.22),T(0.25),T(0.23)	B(0.01),B(0.02),B(0.03),B(0.01)	0.08,0.19	12.83	0.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2191155	2191155	T	C	hom		QUAL=12711;DP=488;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684:intron_variant:MODIFIER:exon1/10:c.103-54A>G::,TH:ENST00000352909:intron_variant:MODIFIER:exon1/12:c.91-54A>G::,TH:ENST00000381175:intron_variant:MODIFIER:exon2/13:c.172-54A>G::,TH:ENST00000381178:intron_variant:MODIFIER:exon2/13:c.184-54A>G::	regulatory_region_variant:enhancer	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925375		0.7035	7931,.		0.4370			0.00,0.06	5.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	6411936	6411941	GCTGGC	-	het		QUAL=30932;DP=1164;AF=0.42;MQM=60	SMPD1	inframe_deletion	SMPD1:ENST00000299397:inframe_deletion:MODERATE:exon1/5:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000342245:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000356761:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000527275:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:	regulatory_region_variant:promoter	607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	256592 [benign DISEASE=not specified,not provided];		(CTGGCG)n (Simple_repeat)	rs3838786		0.2909	2050,.	0.3507,0.1545,0.1048,0.3105,0.2523	0.8620				14.71			gain/donor/6411937-6411936/Medium/2.363419		COSM930080,COSM930081	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73)
chr11	6411935	6411935	T	C	het		QUAL=30932;DP=1164;AF=0.42;MQM=60	SMPD1	missense	SMPD1:ENST00000299397:missense_variant:MODERATE:exon1/5:c.107T>C:p.Val36Ala:,SMPD1:ENST00000342245:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:ENST00000356761:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:ENST00000527275:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:	regulatory_region_variant:promoter	607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	93311 [benign DISEASE=Sphingomyelin/cholesterol lipidosis,not specified,not provided];	CM154141 [CLASS=R MUT=ALT PHEN="Niemann-Pick disease" GENE=SMPD1];	(CTGGCG)n (Simple_repeat)	rs1050228	0.5613	0.5538	3490,.	0.2162,0.7293,0.7682,0.5073,0.5655	0.5010	T(0.48),T(0.56),T(0.42),T(0.56)	B(0.00),B(0.00),B(0.00),B(0.00)	0.05,0.10	8.69	0.03		loss/donor/6411934-6411935/Medium/1.384755			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73)
chr11	6413366	6413366	C	T	het		QUAL=15188;DP=1070;AF=0.51;MQM=60	SMPD1	synonymous	SMPD1:ENST00000299397:synonymous_variant:LOW:exon2/5:c.1071C>T:p.Ala357=:PF00149,SMPD1:ENST00000342245:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:PF00149,SMPD1:ENST00000356761:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:PF00149,SMPD1:ENST00000527275:synonymous_variant:LOW:exon2/6:c.1068C>T:p.Ala356=:PF00149	regulatory_region_variant:promoter	607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	93310 [likely benign(replaced by megSAP based on classifications:3x1,1x2,1x3) DISEASE=Sphingomyelin/cholesterol lipidosis,Niemann-Pick disease, type A,Niemann-Pick disease, type B,not specified,not provided];			rs72896268	0.0034	0.0051	1,.	0.0015,0.0037,0.0000,0.0081,0.0022	-0.3040			0.01,0.16	15.56						1	169	0 / 11					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73)
chr11	6415064	6415064	A	G	het	off-target	QUAL=1526;DP=127;AF=0.50;MQM=60	SMPD1	intron	SMPD1:ENST00000299397:intron_variant:MODIFIER:exon3/4:c.1209-62A>G::,SMPD1:ENST00000342245:intron_variant:MODIFIER:exon4/5:c.1341-62A>G::,SMPD1:ENST00000356761:intron_variant:MODIFIER:exon4/5:c.1173-62A>G::,SMPD1:ENST00000527275:intron_variant:MODIFIER:exon4/5:c.1338-62A>G::		607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];				rs72896272	0.0026	0.0029	0,.		-2.3580			0.01,0.09	0.42						0	91	0 / 6					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73)
chr11	13102890	13102890	C	A	het	off-target	QUAL=69;DP=19;AF=0.32;MQM=60	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.48-26309G>T::						rs2727397	0.5050	0.5693	5247,.		0.0460			0.06,0.20	5.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTC-497E21.5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	13102924	13102924	G	A	het		QUAL=62;DP=20;AF=0.30;MQM=60	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.48-26343C>T::						rs2583136		0.5695	5253,.		-0.4930			0.00,0.07	2.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTC-497E21.5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	26353991	26353991	-	A	hom		QUAL=1996;DP=343;AF=0.54;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon1/26:c.46+139dup::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon1/26:c.-3+22741dup::,ANO3:ENST00000531646:intron_variant:MODIFIER:exon1/4:c.46+139dup::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon2/27:c.-3+22741dup::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs67042303	0.3694	0.3968	2039,.						15.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26465232	26465235	TGTC	-	het		QUAL=822;DP=171;AF=0.36;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon2/26:c.242-80_242-77del::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon2/26:c.194-80_194-77del::,ANO3:ENST00000531646:intron_variant:MODIFIER:exon2/4:c.242-80_242-77del::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon3/27:c.194-80_194-77del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs138185345	0.0308	0.0420	44,.		0.2510				1.04						1	13	1 / 1					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26465500	26465500	G	A	hom		QUAL=5353;DP=180;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon3/26:c.313+117G>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon3/26:c.265+117G>A::,ANO3:ENST00000531646:intron_variant:MODIFIER:exon3/4:c.313+117G>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon4/27:c.265+117G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs4032918	0.6354	0.6701	7395,.		0.0680			0.06,0.28	2.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26481611	26481611	G	A	hom		QUAL=3075;DP=92;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon3/26:c.314-2966G>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon3/26:c.266-2966G>A::,ANO3:ENST00000531646:intron_variant:MODIFIER:exon3/4:c.314-2966G>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon4/27:c.266-2966G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			MSTB (LTR/ERVL-MaLR)	rs2047099		0.9675	13976,.	0.8699,0.9807,0.9981,0.9642,0.9830	-0.2110			0.00,0.04	2.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26547348	26547348	G	A	hom		QUAL=182;DP=6;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon7/26:c.737+122G>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon7/26:c.689+122G>A::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon4/23:c.299+122G>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon8/27:c.689+122G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs430563		0.7609	9003,.		-0.2650			0.01,0.14	0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26547353	26547353	T	G	hom		QUAL=179;DP=6;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon7/26:c.737+127T>G::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon7/26:c.689+127T>G::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon4/23:c.299+127T>G::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon8/27:c.689+127T>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs410617	0.7770	0.7847	9601,.		-1.6280			0.00,0.09	1.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26552679	26552679	T	A	hom		QUAL=30661;DP=959;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon7/26:c.738-73T>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon7/26:c.690-73T>A::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon4/23:c.300-73T>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon8/27:c.690-73T>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs9988806	0.5767	0.5571	5050,.		-2.1680			0.00,0.11	1.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26552696	26552696	T	A	hom		QUAL=35438;DP=1072;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon7/26:c.738-56T>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon7/26:c.690-56T>A::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon4/23:c.300-56T>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon8/27:c.690-56T>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs2131696	0.5767	0.5569	5054,.		-0.4510			0.05,0.19	2.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26552702	26552702	T	C	hom		QUAL=35094;DP=1072;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon7/26:c.738-50T>C::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon7/26:c.690-50T>C::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon4/23:c.300-50T>C::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon8/27:c.690-50T>C::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs293937	0.9896	0.9969	15316,.	0.9596,0.9977,0.9999,0.9999,0.9998	-0.2190			0.05,0.15	0.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26558841	26558841	G	A	hom		QUAL=394;DP=13;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon9/26:c.977-112G>A::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon9/26:c.929-112G>A::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon6/23:c.539-112G>A::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon10/27:c.929-112G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs386635		0.7134	8013,.		-0.1510			0.01,0.13	1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26563464	26563464	A	T	hom		QUAL=3253;DP=113;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon10/26:c.1033-30A>T::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon10/26:c.985-30A>T::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon7/23:c.595-30A>T::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon11/27:c.985-30A>T::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs410036	0.7117	0.7503	8027,.	0.6232,0.8502,0.8273,0.7310,0.7189	0.0730			0.00,0.12	1.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26563652	26563652	T	G	hom		QUAL=4979;DP=153;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon11/26:c.1154+37T>G::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon11/26:c.1106+37T>G::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon8/23:c.716+37T>G::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon12/27:c.1106+37T>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs420143	0.7117	0.7523	8032,.	0.6237,0.8532,0.8282,0.7323,0.7190	-0.4760			0.01,0.15	3.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26568966	26568966	A	G	hom		QUAL=23494;DP=710;AF=1.00;MQM=60	ANO3	synonymous	ANO3:ENST00000256737:synonymous_variant:LOW:exon12/27:c.1158A>G:p.Leu386=:PF04547,ANO3:ENST00000525139:synonymous_variant:LOW:exon12/27:c.1110A>G:p.Leu370=:PF04547,ANO3:ENST00000531568:synonymous_variant:LOW:exon9/24:c.720A>G:p.Leu240=:PF04547,ANO3:ENST00000537978:synonymous_variant:LOW:exon13/28:c.1110A>G:p.Leu370=:PF04547		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs2663168	0.6751	0.6933	6916,.	0.5804,0.7140,0.8174,0.6764,0.6992	-1.2850			0.08,0.91	5.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26569240	26569240	G	-	het		QUAL=1206;DP=56;AF=0.46;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon12/26:c.1289+143del::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon12/26:c.1241+143del::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon9/23:c.851+143del::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon13/27:c.1241+143del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TTTTTTG)n (Simple_repeat)	rs142099565	0.4774	0.4747	3573,.		-3.5130				1.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26569240	26569240	G	T	het		QUAL=1206;DP=56;AF=0.46;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon12/26:c.1289+143G>T::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon12/26:c.1241+143G>T::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon9/23:c.851+143G>T::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon13/27:c.1241+143G>T::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TTTTTTG)n (Simple_repeat)	rs2703409	0.4894	0.1848	548,.		-3.5130			0.00,0.09	3.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26574630	26574630	A	G	hom		QUAL=1931;DP=81;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon12/26:c.1290-166A>G::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon12/26:c.1242-166A>G::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon9/23:c.852-166A>G::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon13/27:c.1242-166A>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs380170	0.9401	0.9262	13456,.		-0.9960			0.00,0.05	4.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26574740	26574740	T	C	hom		QUAL=22848;DP=822;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon12/26:c.1290-56T>C::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon12/26:c.1242-56T>C::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon9/23:c.852-56T>C::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon13/27:c.1242-56T>C::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs395770	0.6765	0.6638	6864,.		-0.4220			0.00,0.05	7.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26574783	26574783	G	-	hom		QUAL=20980;DP=753;AF=0.90;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon12/26:c.1290-13del::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon12/26:c.1242-13del::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon9/23:c.852-13del::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon13/27:c.1242-13del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TGTTT)n (Simple_repeat)	rs59938249	0.9365	0.6862	6529,.	0.5202,0.5663,0.6125,0.5820,0.5990	0.0640				2.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	26581383	26581390	ACACACAC	-	het		QUAL=220;DP=31;AF=0.45;MQM=60	ANO3,MUC15	intron,3'UTR	ANO3:ENST00000256737:intron_variant:MODIFIER:exon14/26:c.1447+89_1447+96del::,MUC15:ENST00000281268:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1222_*1229del::,MUC15:ENST00000436318:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::,MUC15:ENST00000455601:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon14/26:c.1399+89_1399+96del::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon11/23:c.1009+89_1009+96del::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon15/27:c.1399+89_1399+96del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(AC)n (Simple_repeat)	rs150792229		0.1236	215,.		0.3390				1.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58), MUC15 (inh=n/a oe_syn=0.87 oe_mis=1.11 oe_lof=0.70)
chr11	26655627	26655627	-	A	het		QUAL=855;DP=294;AF=0.17;MQM=60	ANO3	intron	ANO3:ENST00000256737:intron_variant:MODIFIER:exon18/26:c.1874-106dup::,ANO3:ENST00000525139:intron_variant:MODIFIER:exon18/26:c.1826-106dup::,ANO3:ENST00000531568:intron_variant:MODIFIER:exon15/23:c.1436-106dup::,ANO3:ENST00000537978:intron_variant:MODIFIER:exon19/27:c.1826-106dup::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			AluSx1 (SINE/Alu)	rs777737664		0.0037	2,.						0.73						0	5	0 / 0					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)
chr11	108115361	108115361	T	-	hom		QUAL=2231;DP=107;AF=0.93;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon6/62:c.663-144del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon7/63:c.663-144del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs11298747		0.9759	14398,.		-0.8400				1.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	[2] auto-classification 12.11.2017  			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108121411	108121411	T	-	het		QUAL=67;DP=148;AF=0.16;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon9/62:c.1236-3del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon10/63:c.1236-3del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	183771 [likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome];			rs1458765658		0.1362	0,.	0.1691,0.1289,0.1796,0.1308,0.1343	-0.6140				0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108129657	108129657	A	G	het		QUAL=315;DP=38;AF=0.45;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon15/62:c.2377-56A>G::,ATM:ENST00000452508:intron_variant:MODIFIER:exon16/63:c.2377-56A>G::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs672655	0.4764	0.4879	3966,.		1.4540			0.42,0.91	16.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108137775	108137775	T	A	het		QUAL=94;DP=11;AF=0.55;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon16/62:c.2467-123T>A::,ATM:ENST00000452508:intron_variant:MODIFIER:exon17/63:c.2467-123T>A::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			AluSx1 (SINE/Alu)	rs642496		0.6503	6798,.		-1.6900			0.00,0.02	0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108143182	108143182	C	T	het		QUAL=969;DP=100;AF=0.46;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon20/62:c.3078-77C>T::,ATM:ENST00000452508:intron_variant:MODIFIER:exon21/63:c.3078-77C>T::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	439418 [benign DISEASE=not specified];			rs664677	0.6526	0.6332	6416,.		-0.1890			0.00,0.09	3.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108150208	108150208	T	-	het		QUAL=441;DP=53;AF=0.40;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon22/62:c.3285-9del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon23/63:c.3285-9del::	regulatory_region_variant:enhancer	607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	181857 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];		(TTTG)n (Simple_repeat)	rs1799757	0.0675	0.1130	283,.	0.0227,0.0614,0.0063,0.1426,0.0768	0.5990				7.71					COSM5575302,COSM5575303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108151707	108151707	-	A	het		QUAL=3782;DP=318;AF=0.49;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon23/62:c.3403-13dup::,ATM:ENST00000452508:intron_variant:MODIFIER:exon24/63:c.3403-13dup::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3218681		0.5603	4494,.	0.4510,0.6113,0.3791,0.5616,0.6142					0.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108155397	108155397	G	A	het		QUAL=106;DP=24;AF=0.33;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon26/62:c.3993+197G>A::,ATM:ENST00000452508:intron_variant:MODIFIER:exon27/63:c.3993+197G>A::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs654005	0.5276	0.5286	4415,.		-0.2570			0.00,0.09	1.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108170271	108170271	G	A	het		QUAL=640;DP=104;AF=0.44;MQM=60	ATM	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon33/62:c.5006-170G>A::,ATM:ENST00000452508:intron_variant:MODIFIER:exon34/63:c.5006-170G>A::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			AluSx (SINE/Alu)	rs1150203	0.4782	0.4948	4012,.		-1.5610			0.00,0.03	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108175394	108175394	T	C	het		QUAL=325;DP=34;AF=0.50;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616:splice_region_variant&intron_variant:LOW:exon36/62:c.5497-8T>C::,ATM:ENST00000452508:splice_region_variant&intron_variant:LOW:exon37/63:c.5497-8T>C::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	132706 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3092829	0.0132	0.0225	7,.	0.0057,0.0186,0.0003,0.0333,0.0061	1.1230			0.19,0.32	8.42		10.05>8.69		0.000/0.004	COSM5019227	15	881	5 / 281	1	[1] Ilnaz Sepahi 29-03-2016 batch import			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108175462	108175462	G	A	het		QUAL=1104;DP=88;AF=0.51;MQM=60	ATM	missense	ATM:ENST00000278616:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	128458 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.0669	0.1136	286,.	0.0227,0.0613,0.0063,0.1435,0.0772	6.3420	T(0.08),T(0.08)	B(0.02),B(0.02)	0.98,0.99	23.20	0.12		loss/acceptor/108175461-108175462/Medium/2.968693		COSM41596	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108183167	108183167	A	G	hom		QUAL=3554;DP=111;AF=1.00;MQM=60	ATM,C11orf65	missense,intron	ATM:ENST00000278616:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser:,ATM:ENST00000452508:missense_variant:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser:,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.641-3369T>C::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];	133627 [benign DISEASE=not specified];			rs659243	1.0000	1.0000	15702,.	1.0000,1.0000,1.0000,1.0000,1.0000	-1.0580	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.17	12.84	0.02				COSM4590264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108183414	108183415	CT	-	het		QUAL=431;DP=41;AF=0.61;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon40/62:c.6006+191_6006+192del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon41/63:c.6006+191_6006+192del::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.641-3617_641-3616del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			MIRb (SINE/MIR)	rs10588462	0.5180	0.5155	4241,.		0.2320				4.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108187830	108187830	T	A	hom		QUAL=104;DP=4;AF=1.00;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon42/62:c.6199-270T>A::,ATM:ENST00000452508:intron_variant:MODIFIER:exon43/63:c.6199-270T>A::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.641-8032A>T::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			AluJr (SINE/Alu)	rs12807529		0.9955	14792,.		-1.2780			0.00,0.08	2.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108195977	108195977	T	-	het		QUAL=1632;DP=163;AF=0.61;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon45/62:c.6573-42del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon46/63:c.6573-42del::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.641-16179del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			(T)n (Simple_repeat)	rs1282994231		0.5810	2249,.		1.3580				3.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108196713	108196715	ATT	-	het		QUAL=640;DP=75;AF=0.53;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon46/62:c.6808-60_6808-58del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon47/63:c.6808-60_6808-58del::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.641-16917_641-16915del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs3212322	0.4848	0.4926	3951,.		3.0730				4.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108224697	108224697	G	A	hom		QUAL=301;DP=10;AF=1.00;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon60/62:c.8786+90G>A::,ATM:ENST00000452508:intron_variant:MODIFIER:exon61/63:c.8786+90G>A::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.640+31950C>T::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			FLAM_A (SINE/Alu)	rs179108	1.0000	0.9998	15665,.		-0.5090			0.00,0.05	5.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108224796	108224797	AA	-	het		QUAL=65;DP=16;AF=0.25;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon60/62:c.8786+190_8786+191del::,ATM:ENST00000452508:intron_variant:MODIFIER:exon61/63:c.8786+190_8786+191del::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.640+31850_640+31851del::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			(AC)n (Simple_repeat)	rs141328711		0.2315	742,.		-1.7680				0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	[2] auto-classification 12.11.2017  			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108224797	108224797	A	C	het		QUAL=65;DP=16;AF=0.25;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon60/62:c.8786+190A>C::,ATM:ENST00000452508:intron_variant:MODIFIER:exon61/63:c.8786+190A>C::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.640+31850T>G::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];			(AC)n (Simple_repeat)	rs678526	0.5861				-2.4720			0.00,0.03	0.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108225483	108225483	C	T	het		QUAL=3200;DP=219;AF=0.58;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon60/62:c.8787-55C>T::,ATM:ENST00000452508:intron_variant:MODIFIER:exon61/63:c.8787-55C>T::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.640+31164G>A::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs664982		0.5293	4432,.		-1.2540			0.00,0.06	0.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108225661	108225661	A	G	het		QUAL=15209;DP=708;AF=0.76;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616:intron_variant:MODIFIER:exon61/62:c.8850+60A>G::,ATM:ENST00000452508:intron_variant:MODIFIER:exon62/63:c.8850+60A>G::,C11orf65:ENST00000525729:intron_variant:MODIFIER:exon6/6:c.640+30986T>C::		607585 [GENE=ATM PHENOS=Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Autosomal dominant,Somatic mutation/Lymphoma,B-cell non-Hodgkin,somatic/Lymphoma,mantle cell,somatic/T-cell prolymphocytic leukemia,somatic];				rs664143		0.6053	5780,.		-0.7070			0.00,0.06	0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11orf65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr13	41373254	41373254	G	A	het		QUAL=22531;DP=2004;AF=0.47;MQM=60	SLC25A15	synonymous	SLC25A15:ENST00000338625:synonymous_variant:LOW:exon3/7:c.117G>A:p.Thr39=:PF00153		603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];	139125 [benign/likely benign DISEASE=Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,not specified,not provided];			rs41396747	0.0629	0.0789	102,.	0.0894,0.0500,0.0163,0.0946,0.0722	-5.5490			0.08,0.45	2.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83)
chr13	41379272	41379272	C	T	het		QUAL=5867;DP=397;AF=0.58;MQM=60	SLC25A15	synonymous	SLC25A15:ENST00000338625:synonymous_variant:LOW:exon4/7:c.333C>T:p.Ala111=:PF00153		603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];	139126 [benign/likely benign DISEASE=Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,not specified];			rs9577152	0.1134	0.1113	249,.	0.1978,0.0555,0.0655,0.0949,0.0913	-2.8610			0.01,0.13	3.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83)
chr13	52508979	52508979	C	T	het		QUAL=17625;DP=1548;AF=0.50;MQM=60	ATP7B	synonymous	ATP7B:ENST00000242839:synonymous_variant:LOW:exon21/21:c.4311G>A:p.Lys1437=:,ATP7B:ENST00000344297:synonymous_variant:LOW:exon17/17:c.3690G>A:p.Lys1230=:,ATP7B:ENST00000400366:synonymous_variant:LOW:exon22/22:c.3978G>A:p.Lys1326=:,ATP7B:ENST00000400370:synonymous_variant:LOW:exon13/13:c.3021G>A:p.Lys1007=:,ATP7B:ENST00000417240:synonymous_variant:LOW:exon14/14:c.1944G>A:p.Lys648=:,ATP7B:ENST00000418097:synonymous_variant:LOW:exon20/20:c.4116G>A:p.Lys1372=:,ATP7B:ENST00000448424:synonymous_variant:LOW:exon20/20:c.4077G>A:p.Lys1359=:	regulatory_region_variant:CTCF_binding_site	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35732 [benign DISEASE=Wilson disease,not specified];			rs73202048	0.0038	0.0071	1,.	0.0012,0.0028,0.0000,0.0115,0.0061	1.3490			0.66,0.55	1.45						1	198	0 / 14					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52511276	52511277	AA	-	het		QUAL=826;DP=176;AF=0.32;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon19/20:c.4021+135_4021+136del::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon15/16:c.3400+135_3400+136del::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon20/21:c.3688+135_3688+136del::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon11/12:c.2731+135_2731+136del::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon12/13:c.1654+135_1654+136del::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon18/19:c.3826+135_3826+136del::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon18/19:c.3787+135_3787+136del::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];				rs200831452	0.4972	0.5099	2806,.		0.1640				1.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52511362	52511362	C	G	het		QUAL=4254;DP=324;AF=0.60;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon19/20:c.4021+50G>C::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon15/16:c.3400+50G>C::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon20/21:c.3688+50G>C::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon11/12:c.2731+50G>C::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon12/13:c.1654+50G>C::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon18/19:c.3826+50G>C::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon18/19:c.3787+50G>C::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	254770 [benign DISEASE=not specified];			rs9535795	0.5317	0.5663	5007,.	0.5218,0.6340,0.3955,0.5814,0.5209	-0.5090			0.00,0.13	1.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52511606	52511606	G	A	het		QUAL=25823;DP=2069;AF=0.48;MQM=60	ATP7B	splice_region&intron	ATP7B:ENST00000242839:splice_region_variant&intron_variant:LOW:exon18/20:c.3903+6C>T::,ATP7B:ENST00000344297:splice_region_variant&intron_variant:LOW:exon14/16:c.3282+6C>T::,ATP7B:ENST00000400366:splice_region_variant&intron_variant:LOW:exon19/21:c.3570+6C>T::,ATP7B:ENST00000400370:splice_region_variant&intron_variant:LOW:exon10/12:c.2613+6C>T::,ATP7B:ENST00000417240:splice_region_variant&intron_variant:LOW:exon11/13:c.1536+6C>T::,ATP7B:ENST00000418097:splice_region_variant&intron_variant:LOW:exon17/19:c.3708+6C>T::,ATP7B:ENST00000448424:splice_region_variant&intron_variant:LOW:exon17/19:c.3669+6C>T::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35727 [benign DISEASE=Wilson disease,not specified];			rs2282057	0.5018	0.5449	4713,.	0.4748,0.4872,0.3977,0.5741,0.5104	-0.1020			0.01,0.21	0.31		4.22>7.36		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52515354	52515354	A	G	het		QUAL=5332;DP=468;AF=0.49;MQM=60	ATP7B	missense	ATP7B:ENST00000242839:missense_variant:MODERATE:exon16/21:c.3419T>C:p.Val1140Ala:PF00702,ATP7B:ENST00000344297:missense_variant:MODERATE:exon12/17:c.2798T>C:p.Val933Ala:PF00702,ATP7B:ENST00000400366:missense_variant:MODERATE:exon17/22:c.3086T>C:p.Val1029Ala:PF00702,ATP7B:ENST00000400370:missense_variant:MODERATE:exon8/13:c.2129T>C:p.Val710Ala:PF00702,ATP7B:ENST00000417240:missense_variant:MODERATE:exon9/14:c.1052T>C:p.Val351Ala:PF00702,ATP7B:ENST00000418097:missense_variant:MODERATE:exon15/20:c.3224T>C:p.Val1075Ala:PF00702,ATP7B:ENST00000448424:missense_variant:MODERATE:exon15/20:c.3185T>C:p.Val1062Ala:PF00702		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35720 [benign DISEASE=Wilson disease,not specified,not provided];	CM044579 [CLASS=DP MUT=ALT PHEN="Wilson disease" GENE=ATP7B];		rs1801249		0.5726	5181,.	0.5495,0.6371,0.3968,0.5826,0.5213	0.1110	T(1.00),T(1.00),T(1.00),T(1.00),T(0.93),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.03),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17	7.32	0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52515511	52515511	A	-	het		QUAL=41;DP=158;AF=0.16;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon15/20:c.3413-151del::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon11/16:c.2792-151del::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon16/21:c.3080-151del::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon7/12:c.2123-151del::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon8/13:c.1046-151del::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon14/19:c.3218-151del::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon14/19:c.3179-151del::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];				rs377284993		0.0402	5,.		1.3760				1.16						0	43	0 / 0					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52523808	52523808	C	T	het		QUAL=20;DP=12;AF=0.25;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839:missense_variant:MODERATE:exon12/21:c.2855G>A:p.Arg952Lys:PF00122,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon8/16:c.2244+335G>A::,ATP7B:ENST00000400366:missense_variant:MODERATE:exon13/22:c.2522G>A:p.Arg841Lys:PF00122,ATP7B:ENST00000400370:missense_variant:MODERATE:exon4/13:c.1565G>A:p.Arg522Lys:PF00122,ATP7B:ENST00000417240:missense_variant:MODERATE:exon6/14:c.671G>A:p.Arg224Lys:PF00122,ATP7B:ENST00000418097:missense_variant:MODERATE:exon12/20:c.2855G>A:p.Arg952Lys:,ATP7B:ENST00000448424:missense_variant:MODERATE:exon11/20:c.2621G>A:p.Arg874Lys:PF00122		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35708 [benign DISEASE=Wilson disease,not specified];	CM127927 [CLASS=DP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs732774	0.5309	0.5670	5043,.	0.5207,0.6355,0.3963,0.5824,0.5219	2.7820	T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00), ,B(0.02),B(0.03),B(0.00),B(0.00),B(0.00)	0.32,0.98	21.90	0.43					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52524488	52524488	T	C	het		QUAL=4551;DP=388;AF=0.50;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839:missense_variant:MODERATE:exon10/21:c.2495A>G:p.Lys832Arg:PF00122,ATP7B:ENST00000344297:missense_variant:MODERATE:exon7/17:c.2009A>G:p.Lys670Arg:PF00122,ATP7B:ENST00000400366:missense_variant:MODERATE:exon11/22:c.2162A>G:p.Lys721Arg:PF00122,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1286-191A>G::,ATP7B:ENST00000417240:missense_variant:MODERATE:exon4/14:c.311A>G:p.Lys104Arg:PF00122,ATP7B:ENST00000418097:missense_variant:MODERATE:exon10/20:c.2495A>G:p.Lys832Arg:PF00122,ATP7B:ENST00000448424:missense_variant:MODERATE:exon9/20:c.2261A>G:p.Lys754Arg:PF00122		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35707 [benign DISEASE=Wilson disease,not specified,not provided];	CM116966 [CLASS=DFP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs1061472		0.5467	4749,.	0.4862,0.4914,0.3961,0.5741,0.5101	6.2090	T(0.07),T(0.14),T(0.08), ,T(0.10),T(0.08),T(0.06)	B(0.08),P(0.47),B(0.00), ,B(0.01),B(0.32),B(0.01)	0.96,0.99	23.10	0.47					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52524560	52524560	C	T	het		QUAL=1334;DP=165;AF=0.44;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon9/20:c.2448-25G>A::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon6/16:c.1962-25G>A::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon10/21:c.2115-25G>A::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1286-263G>A::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon3/13:c.264-25G>A::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon9/19:c.2448-25G>A::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon8/19:c.2214-25G>A::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	254764 [benign DISEASE=not specified];	CS178155 [CLASS=R MUT=ALT PHEN="Wilson disease" GENE=ATP7B];		rs9526811	0.3069	0.4049	2456,.	0.1123,0.3627,0.3392,0.4695,0.3384	1.8860			0.12,0.19	4.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52531960	52531960	C	T	het		QUAL=2861;DP=294;AF=0.47;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon8/20:c.2356-217G>A::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon5/16:c.1870-217G>A::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon9/21:c.2023-217G>A::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1286-7663G>A::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon2/13:c.172-217G>A::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon8/19:c.2356-217G>A::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon7/19:c.2122-217G>A::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];				rs752569	0.5417	0.5723	5200,.		-0.5610			0.00,0.36	0.61			gain/acceptor/52531960-52531961/Medium/1.058644			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52532039	52532039	T	C	het		QUAL=1177;DP=167;AF=0.43;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon8/20:c.2356-296A>G::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon5/16:c.1870-296A>G::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon9/21:c.2023-296A>G::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1286-7742A>G::,ATP7B:ENST00000417240:intron_variant:MODIFIER:exon2/13:c.172-296A>G::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon8/19:c.2356-296A>G::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon7/19:c.2122-296A>G::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];				rs752570	0.3267	0.3760	2566,.		-0.4880			0.03,0.45	11.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52542796	52542796	T	G	hom		QUAL=9546;DP=341;AF=1.00;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon3/20:c.1544-53A>C::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon3/16:c.1544-53A>C::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon4/21:c.1211-53A>C::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1285+5275A>C::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon3/19:c.1544-53A>C::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon3/19:c.1544-53A>C::,ATP7B:ENST00000542656:intron_variant:MODIFIER:exon2/2:c.1447+1832A>C::	regulatory_region_variant:promoter_flanking_region	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];		CR137942 [CLASS=DP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs2147363	0.6118	0.6950	7640,.		-1.8590			0.00,0.10	0.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52544805	52544805	C	G	het		QUAL=1525;DP=150;AF=0.53;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839:missense_variant:MODERATE:exon3/21:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000344297:missense_variant:MODERATE:exon3/17:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000400366:missense_variant:MODERATE:exon4/22:c.1033G>C:p.Val345Leu:,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1285+3266G>C::,ATP7B:ENST00000418097:missense_variant:MODERATE:exon3/20:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000448424:missense_variant:MODERATE:exon3/20:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000542656:missense_variant:MODERATE:exon2/3:c.1270G>C:p.Val424Leu:	regulatory_region_variant:promoter_flanking_region	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35702 [benign/likely benign DISEASE=Wilson disease,not specified,not provided];	CM1212621 [CLASS=DFP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs1801244	0.3770	0.4400	2920,.	0.2262,0.3875,0.4835,0.4837,0.3472	-1.0040	T(0.45),T(0.66),T(0.46), ,T(0.50),T(0.94),T(0.35)	B(0.00),B(0.03),B(0.02), ,B(0.04),B(0.01),B(0.02)	0.04,0.18	10.35	0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52544978	52544978	T	G	het		QUAL=11759;DP=822;AF=0.57;MQM=60	ATP7B	intron	ATP7B:ENST00000242839:intron_variant:MODIFIER:exon2/20:c.1286-93A>C::,ATP7B:ENST00000344297:intron_variant:MODIFIER:exon2/16:c.1286-93A>C::,ATP7B:ENST00000400366:intron_variant:MODIFIER:exon3/21:c.953-93A>C::,ATP7B:ENST00000400370:intron_variant:MODIFIER:exon2/12:c.1285+3093A>C::,ATP7B:ENST00000418097:intron_variant:MODIFIER:exon2/19:c.1286-93A>C::,ATP7B:ENST00000448424:intron_variant:MODIFIER:exon2/19:c.1286-93A>C::,ATP7B:ENST00000542656:intron_variant:MODIFIER:exon1/2:c.1190-93A>C::	regulatory_region_variant:promoter_flanking_region	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];			LTR33A (LTR/ERVL)	rs3742288	0.3776	0.4197	2914,.		-0.2660			0.00,0.03	0.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52548140	52548140	A	C	het		QUAL=5276;DP=422;AF=0.51;MQM=60	ATP7B	missense	ATP7B:ENST00000242839:missense_variant:MODERATE:exon2/21:c.1216T>G:p.Ser406Ala:PF00403,ATP7B:ENST00000344297:missense_variant:MODERATE:exon2/17:c.1216T>G:p.Ser406Ala:PF00403,ATP7B:ENST00000400366:missense_variant:MODERATE:exon3/22:c.883T>G:p.Ser295Ala:PF00403,ATP7B:ENST00000400370:missense_variant:MODERATE:exon2/13:c.1216T>G:p.Ser406Ala:PF00403,ATP7B:ENST00000418097:missense_variant:MODERATE:exon2/20:c.1216T>G:p.Ser406Ala:PF00403,ATP7B:ENST00000448424:missense_variant:MODERATE:exon2/20:c.1216T>G:p.Ser406Ala:PF00403,ATP7B:ENST00000542656:missense_variant:MODERATE:exon1/3:c.1120T>G:p.Ser374Ala:PF00403		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35701 [benign/likely benign DISEASE=Wilson disease,not specified,not provided];	CM129458 [CLASS=FP MUT=ALT PHEN="Reduced copper accumulation" GENE=ATP7B];		rs1801243	0.3762	0.4450	2977,.	0.1838,0.3865,0.5333,0.4897,0.3519	-0.6680	T(0.79),T(0.49),T(0.63),T(0.52),T(0.79),T(0.63),T(0.88)	B(0.00),B(0.01),B(0.03),B(0.08),B(0.07),B(0.01),B(0.02)	0.08,0.23	8.12	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	52585548	52585548	G	T	hom		QUAL=7883;DP=313;AF=0.96;MQM=60	ATP7B	5'UTR	ATP7B:ENST00000242839:5_prime_UTR_variant:MODIFIER:exon1/21:c.-75C>A::,ATP7B:ENST00000344297:5_prime_UTR_variant:MODIFIER:exon1/17:c.-75C>A::,ATP7B:ENST00000400366:5_prime_UTR_variant:MODIFIER:exon1/22:c.-75C>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	312405 [benign DISEASE=Wilson disease,Congenital disorder of glycosylation,not specified,not provided];	CR129463 [CLASS=FP MUT=ALT PHEN="Increased expression" GENE=ATP7B];		rs2277448	0.5168	0.5846	5824,.		-1.3720			0.02,0.57	9.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)
chr13	79766188	79766188	A	G	het		QUAL=154;DP=20;AF=0.50;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2988039	0.5066	0.4061	3257,.	0.7074,0.4284,0.7053,0.2530,0.3501	-0.9470			0.00,0.07	2.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	55310492	55310492	G	A	het		QUAL=822;DP=117;AF=0.38;MQM=59	GCH1	intron,3'UTR,splice_region&intron	GCH1:ENST00000395514:intron_variant:MODIFIER:exon6/6:c.*16+227C>T::,GCH1:ENST00000491895:3_prime_UTR_variant:MODIFIER:exon6/6:c.*243C>T::,GCH1:ENST00000536224:intron_variant:MODIFIER:exon5/5:c.627-720C>T::,GCH1:ENST00000543643:splice_region_variant&intron_variant:LOW:exon6/6:c.*12+8C>T::		600225 [GENE=GCH1 PHENOS=Dystonia,DOPA-responsive,with or without hyperphenylalaninemia,128230,Autosomal recessive,Autosomal dominant/Hyperphenylalaninemia,BH4-deficient,B,233910,Autosomal recessive];	313386 [benign DISEASE=GTP cyclohydrolase I deficiency,not specified,Dystonia, dopa-responsive];	CR075245 [CLASS=DFP MUT=ALT PHEN="Decreased expression" GENE=GCH1];		rs841	0.2298	0.2185	770,.	0.2059,0.3080,0.3594,0.1979,0.1237	-1.6070			0.02,0.11	0.03				0.000/0.008		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCH1 (inh=AD oe_syn=1.16 oe_mis=0.63 oe_lof=0.08)
chr14	74943295	74943295	T	C	het		QUAL=14120;DP=1082;AF=0.50;MQM=60	NPC2	missense&splice_region	NPC2:ENST00000434013:missense_variant&splice_region_variant:MODERATE:exon5/5:c.442A>G:p.Met148Val:		601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs8021664	0.2698	0.2202	870,.	0.3330,0.3203,0.1614,0.1668,0.2573	-0.4990	T(1.00)	B(0.00)	0.00,0.05	6.41	0.12	11.03>11.43				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67)
chr14	74943426	74943426	C	A	het		QUAL=628;DP=82;AF=0.51;MQM=60	NPC2	intron	NPC2:ENST00000434013:intron_variant:MODIFIER:exon4/4:c.442-131G>T::	regulatory_region_variant:enhancer	601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs10150696	0.2656	0.2165	841,.		0.3730			0.04,0.15	2.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67)
chr14	74951000	74951000	T	G	het		QUAL=33;DP=7;AF=0.43;MQM=60	NPC2	intron	NPC2:ENST00000238633:intron_variant:MODIFIER:exon3/4:c.363+118A>C::,NPC2:ENST00000434013:intron_variant:MODIFIER:exon3/4:c.363+118A>C::,NPC2:ENST00000541064:intron_variant:MODIFIER:exon3/3:c.363+118A>C::,NPC2:ENST00000555619:intron_variant:MODIFIER:exon3/4:c.363+118A>C::,NPC2:ENST00000557510:intron_variant:MODIFIER:exon3/3:c.363+118A>C::		601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs1395152099					0.5590			0.10,0.18	5.74						0	10	0 / 0					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67)
chr14	74951476	74951476	A	C	het		QUAL=534;DP=90;AF=0.29;MQM=60	NPC2	intron	NPC2:ENST00000238633:intron_variant:MODIFIER:exon2/4:c.191-186T>G::,NPC2:ENST00000434013:intron_variant:MODIFIER:exon2/4:c.191-186T>G::,NPC2:ENST00000541064:intron_variant:MODIFIER:exon2/3:c.191-186T>G::,NPC2:ENST00000555619:intron_variant:MODIFIER:exon2/4:c.191-186T>G::,NPC2:ENST00000557510:intron_variant:MODIFIER:exon2/3:c.191-186T>G::		601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];			(A)n (Simple_repeat)	rs8015971		0.1892	609,.		1.4810			0.09,0.14	0.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67)
chr15	72637795	72637795	T	C	hom		QUAL=38936;DP=1237;AF=1.00;MQM=60	HEXA,RP11-106M3.2,RP11-106M3.3	synonymous,non_coding_transcript_exon,3'UTR	HEXA:ENST00000268097:synonymous_variant:LOW:exon13/14:c.1518A>G:p.Glu506=:,RP11-106M3.2:ENST00000379915:non_coding_transcript_exon_variant:MODIFIER:exon5/16:n.609A>G::,HEXA:ENST00000457859:3_prime_UTR_variant:MODIFIER:exon11/11:c.*178A>G::,HEXA:ENST00000566304:synonymous_variant:LOW:exon13/14:c.1551A>G:p.Glu517=:,HEXA:ENST00000567159:synonymous_variant:LOW:exon13/13:c.1518A>G:p.Glu506=:,RP11-106M3.3:ENST00000570175:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.234T>C::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive];	93191 [benign DISEASE=Tay-Sachs disease,not specified,not provided];			rs4777502		0.9705	12841,.	0.6046,0.9815,1.0000,0.9983,0.9991	-0.3750			0.01,0.82	16.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68), RP11-106M3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP11-106M3.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	72638892	72638892	T	C	hom		QUAL=75915;DP=2338;AF=1.00;MQM=60	HEXA,RP11-106M3.2,RP11-106M3.3	missense,intron&non_coding_transcript,intron,non_coding_transcript_exon	HEXA:ENST00000268097:missense_variant:MODERATE:exon11/14:c.1306A>G:p.Ile436Val:PF00728,RP11-106M3.2:ENST00000379915:intron_variant&non_coding_transcript_variant:MODIFIER:exon3/15:n.422-226A>G::,HEXA:ENST00000429918:missense_variant:MODERATE:exon9/10:c.787A>G:p.Ile263Val:PF00728,HEXA:ENST00000457859:intron_variant:MODIFIER:exon9/10:c.498-226A>G::,HEXA:ENST00000566304:missense_variant:MODERATE:exon11/14:c.1339A>G:p.Ile447Val:PF00728,HEXA:ENST00000567159:missense_variant:MODERATE:exon11/13:c.1306A>G:p.Ile436Val:PF00728,RP11-106M3.3:ENST00000570175:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1331T>C::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive];	93189 [benign DISEASE=Tay-Sachs disease,not specified,not provided];			rs1800431	0.8764	0.9703	12846,.	0.6041,0.9812,0.9997,0.9982,0.9984	-0.2010	T(0.29), ,T(0.29), ,T(0.31),T(0.30), 	B(0.00), ,B(0.00), ,B(0.00),B(0.00), 	0.14,0.23	11.51	0.23					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68), RP11-106M3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP11-106M3.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	72668539	72668539	T	C	hom		QUAL=2409;DP=125;AF=1.00;MQM=60	HEXA,HEXA-AS1	5'UTR,non_coding_transcript_exon	HEXA:ENST00000268097:5_prime_UTR_variant:MODIFIER:exon1/14:c.-226A>G::,HEXA-AS1:ENST00000567598:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.86T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive];				rs4777505	0.7975	0.8238	11305,.		0.1070			0.01,0.42	10.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68), HEXA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	28489342	28489342	G	A	het		QUAL=1193;DP=108;AF=0.57;MQM=60	CLN3	intron,intron&NMD_transcript	CLN3:ENST00000333496:intron_variant:MODIFIER:exon13/14:c.985-144C>T::,CLN3:ENST00000354630:intron_variant:MODIFIER:exon13/14:c.1006-144C>T::,CLN3:ENST00000355477:intron_variant:MODIFIER:exon13/14:c.913-144C>T::,CLN3:ENST00000357806:intron_variant:MODIFIER:exon10/11:c.760-144C>T::,CLN3:ENST00000357857:intron_variant:MODIFIER:exon12/13:c.895-144C>T::,CLN3:ENST00000359984:intron_variant:MODIFIER:exon13/14:c.1057-144C>T::,CLN3:ENST00000360019:intron_variant:MODIFIER:exon14/15:c.1057-144C>T::,CLN3:ENST00000395653:intron_variant:MODIFIER:exon11/12:c.757-144C>T::,CLN3:ENST00000535392:intron_variant:MODIFIER:exon11/13:c.823-144C>T::,CLN3:ENST00000565316:intron_variant:MODIFIER:exon12/13:c.1006-144C>T::,CLN3:ENST00000567963:intron_variant:MODIFIER:exon12/12:c.907-386C>T::,CLN3:ENST00000568224:intron_variant&NMD_transcript_variant:MODIFIER:exon11/13:c.823-144C>T::,CLN3:ENST00000569430:intron_variant:MODIFIER:exon15/16:c.1057-144C>T::		607042 [GENE=CLN3 PHENOS=Ceroid lipofuscinosis,neuronal,3,204200,Autosomal recessive];			AluSx (SINE/Alu)	rs28374519	0.4040	0.3362	1940,.		-0.4380			0.00,0.19	0.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLN3 (inh=AR oe_syn=1.13 oe_mis=1.03 oe_lof=0.59)
chr16	29825126	29825126	T	C	hom		QUAL=20351;DP=630;AF=1.00;MQM=60	PRRT2,AC009133.20	synonymous,intron&non_coding_transcript	PRRT2:ENST00000300797:synonymous_variant:LOW:exon2/2:c.751T>C:p.Leu251=:,PRRT2:ENST00000358758:synonymous_variant:LOW:exon2/4:c.751T>C:p.Leu251=:,PRRT2:ENST00000567659:synonymous_variant:LOW:exon2/3:c.751T>C:p.Leu251=:,AC009133.20:ENST00000569039:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.246-3632A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	614386 [GENE=PRRT2 PHENOS=Convulsions,familial infantile,with paroxysmal choreoathetosis,602066,Autosomal dominant/Episodic kinesigenic dyskinesia 1,128200,Autosomal dominant/Seizures,benign familial infantile,2,605751,Autosomal dominant];	167544 [benign DISEASE=not specified];			rs11150573	0.9918	0.9984	15449,.	0.9766,0.9991,1.0000,1.0000,1.0000	0.3360			0.03,0.52	17.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRRT2 (inh=AD oe_syn=1.00 oe_mis=0.96 oe_lof=0.18), AC009133.20 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81816733	81816733	C	T	het		QUAL=2746;DP=291;AF=0.40;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron_variant:MODIFIER:exon1/32:c.-47-2815C>T::		600220 [GENE=PLCG2 PHENOS=Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant/Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant];				rs8045964	0.4241	0.4282	2839,.	0.3924,0.3658,0.2790,0.4221,0.6311	-0.4270			0.00,0.10	1.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81816787	81816787	T	A	hom	off-target	QUAL=8971;DP=290;AF=1.00;MQM=60	PLCG2	intron	PLCG2:ENST00000359376:intron_variant:MODIFIER:exon1/32:c.-47-2761T>A::		600220 [GENE=PLCG2 PHENOS=Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant/Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant];				rs4476171		0.9994	15680,.		-1.8260			0.01,0.14	1.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr17	42427544	42427544	-	AGTC	het	off-target	QUAL=2946;DP=433;AF=0.51;MQM=60	GRN	intron	GRN:ENST00000053867:intron_variant:MODIFIER:exon4/12:c.350-50_350-47dup::,GRN:ENST00000589265:intron_variant:MODIFIER:exon4/8:c.350-50_350-47dup::		138945 [GENE=GRN PHENOS=Aphasia,primary progressive,607485,Autosomal dominant/Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];				rs113219200		0.3230	1793,.						4.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27)
chr17	42427732	42427732	G	A	het		QUAL=6843;DP=667;AF=0.56;MQM=60	GRN	intron	GRN:ENST00000053867:intron_variant:MODIFIER:exon5/12:c.462+24G>A::,GRN:ENST00000589265:intron_variant:MODIFIER:exon5/8:c.462+24G>A::	regulatory_region_variant:CTCF_binding_site	138945 [GENE=GRN PHENOS=Aphasia,primary progressive,607485,Autosomal dominant/Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];	558917 [benign DISEASE=not provided];			rs850713	0.3514	0.2811	1217,.	0.3381,0.2205,0.4923,0.2368,0.3175	-0.8860			0.01,0.20	5.35			loss/donor/42427732-42427733/Medium/5.173082			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27)
chr17	42428538	42428538	G	A	het		QUAL=9600;DP=704;AF=0.51;MQM=60	GRN	splice_region&intron,intron	GRN:ENST00000053867:splice_region_variant&intron_variant:LOW:exon8/12:c.835+7G>A::,GRN:ENST00000589265:intron_variant:MODIFIER:exon5/8:c.463-380G>A::	regulatory_region_variant:CTCF_binding_site	138945 [GENE=GRN PHENOS=Aphasia,primary progressive,607485,Autosomal dominant/Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];	258553 [benign/likely benign DISEASE=Frontotemporal dementia,Frontotemporal dementia, ubiquitin-positive,Ceroid lipofuscinosis, neuronal, 11,not specified,not provided];			rs72824736	0.0220	0.0487	56,.	0.0122,0.0174,0.0000,0.0771,0.0105	0.0830			0.10,0.09	6.18				0.000/0.000		29	841	3 / 71					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27)
chr18	11689522	11689522	T	C	het		QUAL=5544;DP=463;AF=0.57;MQM=60	GNAL	5'UTR	GNAL:ENST00000334049:5_prime_UTR_variant:MODIFIER:exon1/12:c.-41T>C::	regulatory_region_variant:promoter	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs9303742	0.3145	0.3389	2566,.	,,,0.2630,0.5000	-1.6050			0.00,0.13	10.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11824880	11824880	T	A	hom		QUAL=1506;DP=54;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon5/12:c.394-37T>A::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon4/11:c.625-37T>A::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon4/11:c.394-37T>A::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon5/12:c.394-37T>A::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs1647556		0.8134	7809,.	0.5841,0.9034,0.7476,0.8197,0.7789	-1.1750			0.01,0.10	0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11824886	11824886	T	G	hom		QUAL=1487;DP=54;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon5/12:c.394-31T>G::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon4/11:c.625-31T>G::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon4/11:c.394-31T>G::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon5/12:c.394-31T>G::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs1647557	0.6396	0.7589	7811,.	0.4279,0.8899,0.6574,0.7809,0.7083	1.8090			0.37,0.21	4.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11862697	11862697	T	C	het		QUAL=1671;DP=172;AF=0.51;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon7/12:c.546+249T>C::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon6/11:c.777+249T>C::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon6/11:c.546+249T>C::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon7/12:c.546+249T>C::,GNAL:ENST00000602628:intron_variant:MODIFIER:exon2/7:c.-76+249T>C::	regulatory_region_variant:promoter_flanking_region	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs787554		0.6835	7766,.		-1.3640			0.00,0.11	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11864707	11864707	A	G	hom		QUAL=7212;DP=244;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon8/12:c.620+102A>G::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon7/11:c.851+102A>G::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon7/11:c.620+102A>G::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon8/12:c.620+102A>G::,GNAL:ENST00000602628:intron_variant:MODIFIER:exon3/7:c.-2+102A>G::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs4315401	0.9647	0.9689	14765,.		-1.0730			0.00,0.06	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11867297	11867297	C	T	het		QUAL=2551;DP=243;AF=0.42;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon9/12:c.679+72C>T::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon8/11:c.910+72C>T::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon8/11:c.679+72C>T::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon9/12:c.679+72C>T::,GNAL:ENST00000602628:intron_variant:MODIFIER:exon4/7:c.58+72C>T::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2855646	0.2542	0.2592	1196,.		-0.0070			0.00,0.08	5.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11872516	11872516	T	C	het		QUAL=2632;DP=176;AF=0.59;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon11/12:c.931+119T>C::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon10/11:c.1162+119T>C::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon10/11:c.931+119T>C::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon11/12:c.931+119T>C::,GNAL:ENST00000602628:intron_variant:MODIFIER:exon6/7:c.310+119T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2071140	0.2446	0.2527	1077,.		-0.0330			0.02,0.16	3.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	11872573	11872573	C	A	het		QUAL=1029;DP=88;AF=0.59;MQM=60	GNAL	intron	GNAL:ENST00000269162:intron_variant:MODIFIER:exon11/12:c.931+176C>A::,GNAL:ENST00000334049:intron_variant:MODIFIER:exon10/11:c.1162+176C>A::,GNAL:ENST00000423027:intron_variant:MODIFIER:exon10/11:c.931+176C>A::,GNAL:ENST00000535121:intron_variant:MODIFIER:exon11/12:c.931+176C>A::,GNAL:ENST00000602628:intron_variant:MODIFIER:exon6/7:c.310+176C>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2071141	0.2330	0.2389	947,.		-1.8490			0.01,0.25	2.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)
chr18	12348285	12348285	T	C	het		QUAL=16018;DP=1317;AF=0.47;MQM=60	AFG3L2	synonymous	AFG3L2:ENST00000269143:synonymous_variant:LOW:exon13/17:c.1650A>G:p.Glu550=:PF01434		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128287 [benign DISEASE=not specified,Spinocerebellar Ataxia, Dominant,not provided];			rs11553521		0.7762	9507,.	0.7637,0.5679,0.6107,0.7808,0.7839	-0.0740			0.59,0.96	15.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12351342	12351342	C	T	het		QUAL=12101;DP=1054;AF=0.47;MQM=60	AFG3L2	synonymous	AFG3L2:ENST00000269143:synonymous_variant:LOW:exon11/17:c.1389G>A:p.Leu463=:PF00004		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128286 [benign DISEASE=not specified,Spinocerebellar Ataxia, Dominant,not provided];			rs11080572		0.7171	7832,.	0.4841,0.5561,0.6044,0.7793,0.7815	-0.9330			0.09,0.25	3.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12358997	12358997	A	G	het	off-target	QUAL=9940;DP=804;AF=0.51;MQM=60	AFG3L2	intron	AFG3L2:ENST00000269143:intron_variant:MODIFIER:exon7/16:c.753-55T>C::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Spinocerebellar ataxia 28,610246,Autosomal dominant];				rs7407640	0.6302	0.7046	8081,.		-1.9010			0.00,0.02	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12359920	12359920	G	A	het		QUAL=1494;DP=152;AF=0.42;MQM=60	AFG3L2	splice_region&intron	AFG3L2:ENST00000269143:splice_region_variant&intron_variant:LOW:exon7/16:c.752+6C>T::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Spinocerebellar ataxia 28,610246,Autosomal dominant];	136312 [benign DISEASE=not specified,Spinocerebellar Ataxia, Dominant,not provided];			rs8097342	0.6196	0.7145	7788,.	0.4824,0.5558,0.6056,0.7770,0.7708	-0.5940			0.01,0.07	5.12		4.20>6.19		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12377177	12377177	C	G	het		QUAL=10815;DP=920;AF=0.53;MQM=60	AFG3L2	5'UTR	AFG3L2:ENST00000269143:5_prime_UTR_variant:MODIFIER:exon1/17:c.-96G>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Spinocerebellar ataxia 28,610246,Autosomal dominant];	326120 [benign DISEASE=Spinocerebellar Ataxia, Dominant];			rs12327346	0.1883	0.1338	598,.	0.3827,0.1444,0.1518,0.0291,0.0821	-0.4970			0.01,0.48	9.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	19995753	19995753	T	C	hom		QUAL=6433;DP=258;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:						rs9946145	0.6855	0.8553	10184,.	0.3488,0.8771,0.8271,0.9161,0.7923	-0.1350			0.02,0.10	3.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)
chr18	19996011	19996011	G	A	het		QUAL=2859;DP=317;AF=0.47;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:						rs7227477	0.4942	0.5056	3822,.	0.4654,0.6070,0.6150,0.4834,0.4305	0.0500			0.00,0.04	2.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)
chr18	21113285	21113285	T	C	hom		QUAL=1580;DP=49;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon24/24:c.3754+34A>G::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon17/17:c.2800+34A>G::	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	255700 [benign DISEASE=not specified];			rs2510344	0.5222	0.5079	3694,.	0.4801,0.6588,0.6210,0.4709,0.4986	-0.8960			0.08,0.20	2.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21119291	21119291	A	G	hom		QUAL=15778;DP=515;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon19/24:c.2911+28T>C::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon12/17:c.1957+28T>C::	regulatory_region_variant:promoter	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	255695 [benign DISEASE=not specified,not provided];			rs6507720		0.5518	4945,.	0.7131,0.6710,0.6233,0.4712,0.4977	-1.3490			0.04,0.17	2.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21119777	21119777	G	A	hom		QUAL=12369;DP=386;AF=0.99;MQM=60	NPC1	splice_region&synonymous	NPC1:ENST00000269228:splice_region_variant&synonymous_variant:LOW:exon18/25:c.2793C>T:p.Asn931=:,NPC1:ENST00000412552:splice_region_variant&synonymous_variant:LOW:exon11/18:c.1839C>T:p.Asn613=:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	21136 [benign DISEASE=Niemann-Pick disease, type C,Niemann-Pick disease type C1,not specified,not provided];			rs1140458	0.4840	0.4986	3339,.	0.3778,0.6539,0.6224,0.4698,0.4867	4.7400			0.98,0.99	17.22		-0.68>-3.03		0.992/		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21120035	21120035	T	C	hom		QUAL=20742;DP=651;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon17/24:c.2605-70A>G::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon10/17:c.1651-70A>G::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];				rs7239575	0.5867	0.5517	4926,.		-0.4170			0.00,0.14	4.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21120382	21120382	A	-	het		QUAL=13;DP=16;AF=0.25;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon17/24:c.2604+30del::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon10/17:c.1650+30del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	522211 [benign DISEASE=Niemann-Pick disease type C1,not provided];			rs750769471		0.4115	1,.	0.3957,0.4302,0.4210,0.4030,0.4299	0.0860				0.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21120444	21120444	T	C	hom		QUAL=1398;DP=54;AF=0.98;MQM=60	NPC1	missense	NPC1:ENST00000269228:missense_variant:MODERATE:exon17/25:c.2572A>G:p.Ile858Val:,NPC1:ENST00000412552:missense_variant:MODERATE:exon10/18:c.1618A>G:p.Ile540Val:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	21135 [benign DISEASE=Niemann-Pick disease, type C,Niemann-Pick disease type C1,not specified,not provided];			rs1805082	0.4858	0.4994	3340,.	0.3780,0.6542,0.6242,0.4704,0.4898	4.9490	T(0.26),T(0.22)	B(0.02),B(0.02)	0.95,0.98	22.50	0.33					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21123296	21123296	-	A	het		QUAL=484;DP=74;AF=0.36;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon14/24:c.2245+122dup::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon7/17:c.1291+122dup::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs34563465	0.4768	0.5514	1883,.						0.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21123537	21123537	A	-	het		QUAL=3279;DP=440;AF=0.40;MQM=60	NPC1	splice_region&intron	NPC1:ENST00000269228:splice_region_variant&intron_variant:LOW:exon13/24:c.2131-4del::,NPC1:ENST00000412552:splice_region_variant&intron_variant:LOW:exon6/17:c.1177-4del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	403254 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided];		(A)n (Simple_repeat)	rs11299077		0.6374	5071,.	0.4657,0.4708,0.4747,0.4543,0.4657	-0.4120				0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21124907	21124907	-	CCCC	hom		QUAL=3159;DP=136;AF=0.13;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon12/24:c.1947+13_1947+16dup::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon5/17:c.993+13_993+16dup::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	92703 [benign DISEASE=Niemann-Pick disease type C1,not specified];			rs55809701									1.02						166	16	6 / 1	2	[2] Julia Bickmann 23.09.2014			NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21124917	21124917	G	C	hom		QUAL=3159;DP=136;AF=0.13;MQM=60	NPC1	splice_region&intron	NPC1:ENST00000269228:splice_region_variant&intron_variant:LOW:exon12/24:c.1947+7C>G::,NPC1:ENST00000412552:splice_region_variant&intron_variant:LOW:exon5/17:c.993+7C>G::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];				rs56394541		0.0010	0,.	0.0003,0.0013,0.0010,0.0003,0.0010	-0.1620			0.02,0.25	0.30				0.000/0.000		85	31	1 / 1	2	[2] Stefanie Beck-Woedl 20.03.2015			NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21124945	21124945	C	G	hom		QUAL=6347;DP=257;AF=0.93;MQM=60	NPC1	missense	NPC1:ENST00000269228:missense_variant:MODERATE:exon12/25:c.1926G>C:p.Met642Ile:,NPC1:ENST00000412552:missense_variant:MODERATE:exon5/18:c.972G>C:p.Met324Ile:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	92701 [benign DISEASE=Niemann-Pick disease, type C,Niemann-Pick disease type C1,not specified,not provided];			rs1788799		0.7422	8498,.	0.9243,0.8278,0.9346,0.6528,0.7684	3.3040	T(1.00),T(1.00)	B(0.00),B(0.00)	0.22,0.96	18.56	0.26					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21127910	21127910	C	T	hom		QUAL=41145;DP=1253;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon11/24:c.1757+60G>A::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon4/17:c.804-2797G>A::	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];				rs2435307	0.4910	0.4688	3455,.		0.1120			0.00,0.09	1.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21134570	21134571	AA	-	het		QUAL=1372;DP=134;AF=0.22;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon9/24:c.1553+151_1553+152del::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon4/17:c.803+151_803+152del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs201731344		0.0412	83,.		-0.1020				1.47			gain/acceptor/21134571-21134572/Medium/4.254077			0	23	0 / 4					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21134570	21134570	A	-	het		QUAL=1372;DP=134;AF=0.46;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon9/24:c.1553+152del::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon4/17:c.803+152del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs1227245596		0.5606	3259,.		-0.1020				1.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21137442	21137442	A	G	hom		QUAL=82;DP=4;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228:intron_variant:MODIFIER:exon6/24:c.882-288T>C::,NPC1:ENST00000412552:intron_variant:MODIFIER:exon1/17:c.81-288T>C::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];			AluSc (SINE/Alu)	rs1788760		0.7569	9175,.		-1.2880			0.00,0.03	1.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr18	21140432	21140432	T	C	hom		QUAL=30689;DP=933;AF=1.00;MQM=60	NPC1	missense	NPC1:ENST00000269228:missense_variant:MODERATE:exon6/25:c.644A>G:p.His215Arg:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type C1,257220,Autosomal recessive/Niemann-Pick disease,type D,257220,Autosomal recessive];	92714 [benign DISEASE=Niemann-Pick disease, type C,Niemann-Pick disease type C1,not specified,not provided];			rs1805081	0.2186	0.3307	1882,.	0.0702,0.2468,0.2463,0.4039,0.2779	0.5900	T(0.58)	B(0.00)	0.28,0.26	9.04	0.15					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)
chr19	6495736	6495736	A	G	hom		QUAL=9129;DP=330;AF=1.00;MQM=60	TUBB4A	synonymous	TUBB4A:ENST00000264071:synonymous_variant:LOW:exon4/4:c.774T>C:p.Val258=:,TUBB4A:ENST00000540257:synonymous_variant:LOW:exon4/5:c.774T>C:p.Val258=:		602662 [GENE=TUBB4A PHENOS=Dystonia 4,torsion,autosomal dominant,128101,Autosomal dominant/Leukodystrophy,hypomyelinating,6,612438,Autosomal dominant];	330263 [benign DISEASE=Dystonia,Leukodystrophy, hypomyelinating, 6];			rs2071347	0.6294	0.7019	7782,.	0.6893,0.7411,0.4502,0.7059,0.5406	-0.0300			0.36,0.94	14.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBB4A (inh=AD oe_syn=1.16 oe_mis=0.31 oe_lof=0.29)
chr19	13002033	13002033	A	G	hom		QUAL=4653;DP=168;AF=1.00;MQM=60	GCDH	intron,5'UTR	GCDH:ENST00000222214:intron_variant:MODIFIER:exon1/11:c.-35+17A>G::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon1/11:c.-222+17A>G::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon1/11:c.-35+17A>G::,GCDH:ENST00000591470:5_prime_UTR_variant:MODIFIER:exon1/11:c.-86A>G::	regulatory_region_variant:promoter	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs7251834	0.9778	0.9710	14813,.		0.4280			0.00,0.27	10.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13002400	13002400	G	C	het		QUAL=13840;DP=1244;AF=0.47;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon3/11:c.127+64G>C::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon3/11:c.-61+64G>C::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon3/11:c.127+64G>C::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon2/10:c.127+64G>C::	regulatory_region_variant:promoter	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs1799918	0.2532	0.3302	1549,.	0.2116,0.4451,0.1423,0.3693,0.2667	0.0810			0.05,0.12	9.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13002563	13002563	T	G	het		QUAL=2653;DP=333;AF=0.45;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon3/11:c.128-82T>G::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon3/11:c.-60-82T>G::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon3/11:c.128-82T>G::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon2/10:c.128-82T>G::	regulatory_region_variant:promoter	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs2242517	0.4040	0.4400	3212,.		-0.2370			0.00,0.05	8.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13006592	13006593	TT	-	het		QUAL=512;DP=146;AF=0.20;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon6/11:c.506-195_506-194del::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon6/11:c.374-195_374-194del::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon6/11:c.506-195_506-194del::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon5/10:c.506-195_506-194del::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs559507975	0.3860	0.3525	949,.		0.1400				0.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13006685	13006685	T	C	het		QUAL=617;DP=211;AF=0.39;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon6/11:c.506-121T>C::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon6/11:c.374-121T>C::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon6/11:c.506-121T>C::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon5/10:c.506-121T>C::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs2238641	0.2798	0.3256	1708,.		-0.8430			0.00,0.04	0.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13006687	13006687	G	A	het		QUAL=617;DP=211;AF=0.39;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon6/11:c.506-119G>A::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon6/11:c.374-119G>A::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon6/11:c.506-119G>A::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon5/10:c.506-119G>A::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs12151303	0.3347	0.3764	2311,.		0.2140			0.00,0.07	1.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13007458	13007458	C	T	het		QUAL=1267;DP=151;AF=0.48;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon8/11:c.852+223C>T::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon8/11:c.720+223C>T::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon8/11:c.852+223C>T::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon7/10:c.852+223C>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	221908 [likely pathogenic DISEASE=Glutaric aciduria, type 1];			rs11085825	0.2540	0.3005	1525,.		-0.0360			0.24,0.13	3.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13008264	13008264	C	T	het		QUAL=6782;DP=975;AF=0.43;MQM=60	GCDH	intron	GCDH:ENST00000222214:intron_variant:MODIFIER:exon10/11:c.1082+22C>T::,GCDH:ENST00000422947:intron_variant:MODIFIER:exon10/11:c.950+22C>T::,GCDH:ENST00000457854:intron_variant:MODIFIER:exon10/11:c.1082+22C>T::,GCDH:ENST00000591470:intron_variant:MODIFIER:exon9/10:c.1082+22C>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs201346843	0.0004	0.0038	0,.	0.0005,0.0033,0.0000,0.0065,0.0002	-2.7820			0.00,0.10	0.03						0	51	0 / 7					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13008607	13008607	G	T	het		QUAL=32909;DP=2878;AF=0.49;MQM=60	GCDH	synonymous	GCDH:ENST00000222214:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:PF00441,GCDH:ENST00000422947:synonymous_variant:LOW:exon11/12:c.1041G>T:p.Gly347=:PF00441,GCDH:ENST00000457854:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:PF00441,GCDH:ENST00000591470:synonymous_variant:LOW:exon10/11:c.1173G>T:p.Gly391=:PF00441		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	92529 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1,not specified,not provided];			rs1060218	0.2504	0.3303	1491,.	0.1988,0.4473,0.1392,0.3704,0.2671	-1.1720			0.09,0.55	10.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)
chr19	13010520	13010520	A	G	het		QUAL=11939;DP=1010;AF=0.46;MQM=60	GCDH,SYCE2	3'UTR,intron,missense	GCDH:ENST00000222214:3_prime_UTR_variant:MODIFIER:exon12/12:c.*165A>G::,SYCE2:ENST00000293695:intron_variant:MODIFIER:exon5/5:c.612+298T>C::,GCDH:ENST00000422947:3_prime_UTR_variant:MODIFIER:exon12/12:c.*165A>G::,GCDH:ENST00000457854:missense_variant:MODERATE:exon12/12:c.1250A>G:p.Gln417Arg:,GCDH:ENST00000591470:3_prime_UTR_variant:MODIFIER:exon11/11:c.*165A>G::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	208504 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1];			rs8012	0.7204	0.6313	6520,.	0.8298,0.7109,0.7796,0.5497,0.6707	0.3260	 , , ,D(0.00), 	 , , ,B(0.00), 	0.11,0.17	0.78	0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)
chr19	13010643	13010643	G	T	het		QUAL=2874;DP=342;AF=0.37;MQM=60	GCDH,SYCE2	3'UTR,intron	GCDH:ENST00000222214:3_prime_UTR_variant:MODIFIER:exon12/12:c.*288G>T::,SYCE2:ENST00000293695:intron_variant:MODIFIER:exon5/5:c.612+175C>A::,GCDH:ENST00000422947:3_prime_UTR_variant:MODIFIER:exon12/12:c.*288G>T::,GCDH:ENST00000457854:3_prime_UTR_variant:MODIFIER:exon12/12:c.*86G>T::,GCDH:ENST00000591470:3_prime_UTR_variant:MODIFIER:exon11/11:c.*288G>T::	regulatory_region_variant:promoter_flanking_region	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	208505 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1];			rs9384	0.2780	0.3238	1716,.		-1.7060			0.01,0.09	1.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)
chr19	30193721	30193721	G	A	het		QUAL=12240;DP=1299;AF=0.40;MQM=60	C19orf12	synonymous,intron	C19orf12:ENST00000323670:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:,C19orf12:ENST00000392276:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:ENST00000392278:synonymous_variant:LOW:exon3/3:c.357C>T:p.Thr119=:,C19orf12:ENST00000592153:intron_variant:MODIFIER:exon3/3:c.291-22C>T::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	614297 [GENE=C19ORF12 PHENOS=Neurodegeneration with brain iron accumulation 4,614298,Autosomal recessive/Spastic paraplegia 43,autosomal recessive,615043,Autosomal recessive];	128537 [benign DISEASE=Neurodegeneration with brain iron accumulation 4,not specified];			rs10424582	0.6138	0.7176	8196,.	0.7766,0.4518,0.3019,0.7516,0.6448	0.1170			0.04,0.21	0.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C19orf12 (inh=AR oe_syn=1.15 oe_mis=0.89 oe_lof=0.22)
chr19	42470962	42470962	T	G	het		QUAL=144;DP=29;AF=0.52;MQM=56	ATP1A3	3'UTR	ATP1A3:ENST00000302102:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000543770:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000545399:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000602133:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::		182350 [GENE=ATP1A3 PHENOS=Alternating hemiplegia of childhood 2,614820,Autosomal dominant/CAPOS syndrome,601338,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];				rs782239785		0.1239	0,.	0.0024,0.0006,0.0035,0.0104,0.0008	-0.1880			0.02,0.11	1.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)
chr19	42471050	42471050	G	C	het		QUAL=16600;DP=1200;AF=0.57;MQM=60	ATP1A3	3'UTR	ATP1A3:ENST00000302102:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000543770:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000545399:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000602133:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::		182350 [GENE=ATP1A3 PHENOS=Alternating hemiplegia of childhood 2,614820,Autosomal dominant/CAPOS syndrome,601338,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];	329400 [benign DISEASE=Alternating hemiplegia of childhood,Dystonia 12];			rs919390	0.7194	0.6996	7653,.	0.7727,0.6100,0.8135,0.6496,0.5833	4.2940			0.95,0.94	8.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)
chr19	42474950	42474950	-	T	het		QUAL=177;DP=38;AF=0.53;MQM=60	ATP1A3	intron	ATP1A3:ENST00000302102:intron_variant:MODIFIER:exon16/22:c.2264-257dup::,ATP1A3:ENST00000543770:intron_variant:MODIFIER:exon16/22:c.2297-257dup::,ATP1A3:ENST00000545399:intron_variant:MODIFIER:exon16/22:c.2303-257dup::,ATP1A3:ENST00000602133:intron_variant:MODIFIER:exon16/22:c.2174-257dup::		182350 [GENE=ATP1A3 PHENOS=Alternating hemiplegia of childhood 2,614820,Autosomal dominant/CAPOS syndrome,601338,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];			AluY (SINE/Alu)	rs538733809	0.0022	0.0023	0,.						1.56						0	7	0 / 0					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)
chr19	42489516	42489516	A	C	hom		QUAL=25182;DP=808;AF=1.00;MQM=60	ATP1A3	synonymous	ATP1A3:ENST00000302102:synonymous_variant:LOW:exon7/23:c.666T>G:p.Thr222=:PF00122,ATP1A3:ENST00000543770:synonymous_variant:LOW:exon7/23:c.699T>G:p.Thr233=:PF00122,ATP1A3:ENST00000545399:synonymous_variant:LOW:exon7/23:c.705T>G:p.Thr235=:PF00122,ATP1A3:ENST00000602133:synonymous_variant:LOW:exon7/23:c.576T>G:p.Thr192=:PF00122		182350 [GENE=ATP1A3 PHENOS=Alternating hemiplegia of childhood 2,614820,Autosomal dominant/CAPOS syndrome,601338,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];	157926 [benign/likely benign DISEASE=Alternating hemiplegia of childhood,Dystonia 12,not specified,not provided];			rs2217342		0.9314	13631,.	0.9852,0.8576,0.8702,0.9021,0.8147	-4.1090			0.02,0.13	0.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)
chr19	49469087	49469087	T	C	hom		QUAL=33683;DP=1199;AF=1.00;MQM=60	FTL	synonymous	FTL:ENST00000331825:synonymous_variant:LOW:exon2/4:c.163T>C:p.Leu55=:PF00210	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	134790 [GENE=FTL PHENOS=Hyperferritinemia-cataract syndrome,600886,Autosomal dominant/L-ferritin deficiency,dominant and recessive,615604,Autosomal recessive,Autosomal dominant/Neurodegeneration with brain iron accumulation 3,606159,Autosomal dominant];	156440 [benign DISEASE=Hyperferritinemia cataract syndrome,Neuroferritinopathy,Glycogen storage disease 0, muscle,not specified,sporadic abdominal aortic aneurysm];			rs2230267	0.4607	0.5065	4049,.	0.4794,0.5264,0.4254,0.5413,0.3964	-0.4260			0.21,0.51	17.12			gain/acceptor/49469086-49469087/Medium/4.040463			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FTL (inh=AR+AD oe_syn=0.99 oe_mis=1.13 oe_lof=1.62)
chr19	49469986	49469986	C	T	het		QUAL=4457;DP=339;AF=0.50;MQM=60	FTL	synonymous	FTL:ENST00000331825:synonymous_variant:LOW:exon4/4:c.522C>T:p.His174=:	regulatory_region_variant:promoter	134790 [GENE=FTL PHENOS=Hyperferritinemia-cataract syndrome,600886,Autosomal dominant/L-ferritin deficiency,dominant and recessive,615604,Autosomal recessive,Autosomal dominant/Neurodegeneration with brain iron accumulation 3,606159,Autosomal dominant];	329787 [likely benign DISEASE=Hyperferritinemia cataract syndrome,Neuroferritinopathy];			rs73046709	0.0006	0.0022	0,.	0.0002,0.0001,0.0001,0.0042,0.0000	-1.7050			0.49,0.91	17.62						0	44	0 / 7					FTL (inh=AR+AD oe_syn=0.99 oe_mis=1.13 oe_lof=1.62)
chr20	3870124	3870124	G	C	hom		QUAL=20023;DP=734;AF=1.00;MQM=60	PANK2	missense,intron	PANK2:ENST00000316562:missense_variant:MODERATE:exon1/7:c.377G>C:p.Gly126Ala:,PANK2:ENST00000497424:intron_variant:MODIFIER:exon1/6:c.-246+573G>C::,PANK2:ENST00000610179:missense_variant:MODERATE:exon1/7:c.8G>C:p.Gly3Ala:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];	96526 [benign DISEASE=Pigmentary pallidal degeneration,not specified,not provided];			rs3737084		0.8965	12648,.	0.9830,0.9319,0.8025,0.8754,0.7596	1.0190	T(1.00), ,T(1.00)	B(0.00), ,B(0.00)	0.03,0.98	23.20	0.27					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)
chr20	3888337	3888337	A	G	hom		QUAL=1819;DP=74;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562:intron_variant:MODIFIER:exon1/6:c.629-236A>G::,PANK2:ENST00000497424:intron_variant:MODIFIER:exon1/6:c.-245-236A>G::,PANK2:ENST00000610179:intron_variant:MODIFIER:exon1/6:c.260-236A>G::		606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];				rs6116087		0.6784	7253,.		-0.9780			0.01,0.11	5.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)
chr20	3897871	3897871	A	T	hom	off-target	QUAL=184;DP=10;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562:intron_variant:MODIFIER:exon5/6:c.1536+174A>T::,PANK2:ENST00000497424:intron_variant:MODIFIER:exon5/6:c.663+174A>T::,PANK2:ENST00000610179:intron_variant:MODIFIER:exon5/6:c.1167+174A>T::		606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];									-0.3070			0.00,0.08	3.63						42	0	0 / 0	2	[2] auto-classification 24.11.2017  			PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)
chr20	3903634	3903634	C	T	hom		QUAL=1192;DP=57;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562:intron_variant:MODIFIER:exon6/6:c.1663-257C>T::,PANK2:ENST00000497424:intron_variant:MODIFIER:exon6/6:c.790-257C>T::,PANK2:ENST00000610179:intron_variant:MODIFIER:exon6/6:c.1294-257C>T::	regulatory_region_variant:promoter_flanking_region	606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];				rs11906612	0.0633	0.1188	317,.		-0.0330			0.04,0.18	1.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)
chr20	14167283	14167283	A	G	hom		QUAL=962;DP=40;AF=0.98;MQM=60	MACROD2	intron	MACROD2:ENST00000217246:intron_variant:MODIFIER:exon3/16:c.271+100909A>G::,MACROD2:ENST00000310348:intron_variant:MODIFIER:exon3/17:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.4792	0.5396	4941,.		-0.5350			0.01,0.34	9.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	48301146	48301146	G	A	hom		QUAL=3273;DP=109;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:ENST00000371711:intron_variant:MODIFIER:exon1/8:c.116-27907C>T::						rs6512586	0.4681	0.5178	3527,.	0.3755,0.4483,0.3696,0.5460,0.6515	-0.9860			0.00,0.05	0.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr22	38512402	38512402	G	A	het		QUAL=19400;DP=1471;AF=0.50;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon12/16:c.1743-184C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon11/15:c.1581-184C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon11/15:c.1581-184C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			L1ME4b (LINE/L1)	rs11089863	0.3001	0.3587	1659,.	0.2413,0.4221,0.1362,0.3662,0.4204	1.3780			0.02,0.11	6.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38512562	38512562	G	A	het		QUAL=3279;DP=246;AF=0.60;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon12/16:c.1743-344C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon11/15:c.1581-344C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon11/15:c.1581-344C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			L1M5 (LINE/L1)	rs12167576	0.3033	0.3195	1674,.		-0.8260			0.00,0.04	2.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38518962	38518971	CCCGCCCCTG	-	het		QUAL=538;DP=114;AF=0.48;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon11/16:c.1591+131_1591+140del::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon10/15:c.1429+131_1429+140del::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon10/15:c.1429+131_1429+140del::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs11570732	0.1290	0.1069	200,.		0.1900				2.24			gain/donor/38518969-38518970/Medium/2.648323			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38519513	38519513	T	C	het		QUAL=627;DP=61;AF=0.57;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon10/16:c.1428-248A>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon9/15:c.1266-248A>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon9/15:c.1266-248A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs2076117	0.1288	0.1080	226,.		-0.8610			0.01,0.11	2.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38523211	38523211	G	A	het		QUAL=712;DP=63;AF=0.60;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon9/16:c.1349-755C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon8/15:c.1187-755C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon8/15:c.1187-755C>T::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs3788532	0.3069	0.3308	1933,.		-1.0010			0.02,0.16	1.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38523246	38523246	C	G	hom		QUAL=4324;DP=205;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon9/16:c.1349-790G>C::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon8/15:c.1187-790G>C::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon8/15:c.1187-790G>C::	regulatory_region_variant:TF_binding_site	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs3788533	0.4487	0.4501	3333,.		-2.7680			0.02,0.16	2.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38524149	38524149	G	C	het		QUAL=3213;DP=254;AF=0.58;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon9/16:c.1348+127C>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon8/15:c.1186+1312C>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon8/15:c.1186+1312C>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs9622732	0.2790	0.2801	1368,.		-4.0600			0.01,0.11	0.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38530956	38530956	G	A	het		QUAL=8690;DP=871;AF=0.46;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon6/16:c.894+39C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon6/15:c.894+39C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon6/15:c.894+39C>T::	regulatory_region_variant:enhancer	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs2272831	0.1116	0.0953	133,.	0.1068,0.0470,0.1459,0.0947,0.1422	0.1430			0.06,0.14	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38535946	38535946	G	A	het		QUAL=4791;DP=516;AF=0.45;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon5/16:c.797+43C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon5/15:c.797+43C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon5/15:c.797+43C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs12329956	0.2798	0.3471	1472,.	0.1565,0.4157,0.1357,0.3607,0.4163	-0.2760			0.03,0.25	12.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38539041	38539041	T	C	hom		QUAL=5989;DP=213;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon4/16:c.609+71A>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon4/15:c.609+71A>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon4/15:c.609+71A>G::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon3/3:c.425+2404A>G::	regulatory_region_variant:enhancer	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs4375	0.4976	0.4654	3606,.		-0.5510			0.00,0.15	13.17			loss/acceptor/38539041-38539042/Medium/7.276764			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38540838	38540847	ATAAAATAAA	-	het		QUAL=569;DP=45;AF=0.53;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon3/16:c.425+598_425+607del::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon3/15:c.425+598_425+607del::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon3/15:c.425+598_425+607del::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon3/3:c.425+598_425+607del::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			(ATAAA)n (Simple_repeat)	rs149247706		0.3396	1595,.		0.1320				0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38540838	38540842	ATAAA	-	het		QUAL=569;DP=45;AF=0.53;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon3/16:c.425+603_425+607del::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon3/15:c.425+603_425+607del::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon3/15:c.425+603_425+607del::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon3/3:c.425+603_425+607del::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			(ATAAA)n (Simple_repeat)	rs132935		0.1062	180,.		0.1320				0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38541040	38541040	T	-	het		QUAL=312;DP=474;AF=0.27;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon3/16:c.425+405del::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon3/15:c.425+405del::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon3/15:c.425+405del::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon3/3:c.425+405del::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			AluJr4 (SINE/Alu)	rs1200313319					0.2800										65	725	1 / 1	2	[2] auto-classification 25.11.2017  			PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38541266	38541266	T	C	het		QUAL=864;DP=94;AF=0.43;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon3/16:c.425+179A>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon3/15:c.425+179A>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon3/15:c.425+179A>G::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon3/3:c.425+179A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			AluJr4 (SINE/Alu)	rs1005529	0.4694	0.4444	3149,.		-0.9490			0.00,0.03	2.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38541779	38541779	C	T	hom		QUAL=65;DP=4;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.210-119G>A::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.210-119G>A::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.210-119G>A::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon3/3:c.*41-119G>A::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon3/3:c.*41-119G>A::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.210-119G>A::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon3/3:c.*41-119G>A::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];									-0.7000			0.02,0.18	6.94						9	0	0 / 0					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38541936	38541936	G	A	het		QUAL=16;DP=19;AF=0.32;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.210-276C>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.210-276C>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.210-276C>T::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon3/3:c.*41-276C>T::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon3/3:c.*41-276C>T::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.210-276C>T::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon3/3:c.*41-276C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			AluJr (SINE/Alu)	rs4821748	0.3219	0.3237	1694,.		-0.5720			0.00,0.08	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38543453	38543453	T	C	het		QUAL=10829;DP=788;AF=0.57;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.210-1793A>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.210-1793A>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.210-1793A>G::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon3/3:c.*40+1047A>G::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon3/3:c.*40+1047A>G::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.210-1793A>G::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon3/3:c.*40+1047A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];				rs2284060	0.4201	0.4101	2668,.		-0.8520			0.00,0.07	3.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38559448	38559448	C	A	het		QUAL=21989;DP=1662;AF=0.50;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.209+5777G>T::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.209+5777G>T::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.209+5777G>T::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon2/3:c.209+5777G>T::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon2/3:c.209+5777G>T::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.209+5777G>T::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon2/3:c.209+5777G>T::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			L2b (LINE/L2)	rs731821	0.4147	0.3847	2387,.		-0.7940			0.00,0.07	2.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38563972	38563972	T	C	het		QUAL=26166;DP=1884;AF=0.51;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.209+1253A>G::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.209+1253A>G::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.209+1253A>G::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon2/3:c.209+1253A>G::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon2/3:c.209+1253A>G::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.209+1253A>G::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon2/3:c.209+1253A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			L2b (LINE/L2)	rs132988	0.1304	0.1105	234,.		0.3680			0.00,0.05	7.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38564041	38564041	C	G	het		QUAL=17732;DP=1411;AF=0.51;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509:intron_variant:MODIFIER:exon2/16:c.209+1184G>C::,PLA2G6:ENST00000335539:intron_variant:MODIFIER:exon2/15:c.209+1184G>C::,PLA2G6:ENST00000402064:intron_variant:MODIFIER:exon2/15:c.209+1184G>C::,PLA2G6:ENST00000417303:intron_variant:MODIFIER:exon2/3:c.209+1184G>C::,PLA2G6:ENST00000435484:intron_variant:MODIFIER:exon2/3:c.209+1184G>C::,PLA2G6:ENST00000436218:intron_variant:MODIFIER:exon2/3:c.209+1184G>C::,PLA2G6:ENST00000447598:intron_variant:MODIFIER:exon2/3:c.209+1184G>C::	regulatory_region_variant:CTCF_binding_site	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive];			L2b (LINE/L2)	rs9622746	0.2951	0.2987	1514,.		0.0510			0.01,0.10	1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	51063987	51063987	G	C	hom		QUAL=15228;DP=620;AF=0.99;MQM=60	ARSA	intron	ARSA:ENST00000216124:intron_variant:MODIFIER:exon7/7:c.1210+20C>G::,ARSA:ENST00000356098:intron_variant:MODIFIER:exon8/8:c.1210+20C>G::,ARSA:ENST00000395619:intron_variant:MODIFIER:exon8/8:c.1210+20C>G::,ARSA:ENST00000395621:intron_variant:MODIFIER:exon8/8:c.1210+20C>G::,ARSA:ENST00000453344:intron_variant:MODIFIER:exon7/7:c.952+20C>G::,ARSA:ENST00000547307:intron_variant:MODIFIER:exon7/7:c.1204+20C>G::,ARSA:ENST00000547805:intron_variant:MODIFIER:exon8/8:c.1204+20C>G::		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	93118 [benign DISEASE=not specified,not provided];			rs762674		0.8022	9361,.	0.7220,0.8629,0.9786,0.7716,0.8087	-0.0920			0.02,0.25	1.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chr22	51064039	51064039	G	C	hom		QUAL=29583;DP=1082;AF=1.00;MQM=60	ARSA	missense	ARSA:ENST00000216124:missense_variant:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser:PF14707,ARSA:ENST00000356098:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707,ARSA:ENST00000395619:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707,ARSA:ENST00000395621:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707,ARSA:ENST00000453344:missense_variant:MODERATE:exon7/8:c.920C>G:p.Thr307Ser:PF14707,ARSA:ENST00000547307:missense_variant:MODERATE:exon7/8:c.1172C>G:p.Thr391Ser:PF14707,ARSA:ENST00000547805:missense_variant:MODERATE:exon8/9:c.1172C>G:p.Thr391Ser:PF14707		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	21184 [benign DISEASE=Metachromatic leukodystrophy,not specified,not provided];	CM910052 [CLASS=DP MUT=ALT PHEN="Phenotype modifier association with" GENE=ARSA];		rs743616	0.4056	0.4974	3982,.	0.3836,0.4184,0.2914,0.5405,0.4228	0.1010	T(0.42),T(0.42),T(0.42),T(0.42),T(0.42),T(0.42),T(0.42)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.02,0.18	11.74	0.29					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chr22	51064141	51064141	G	A	hom		QUAL=16777;DP=619;AF=1.00;MQM=60	ARSA	intron	ARSA:ENST00000216124:intron_variant:MODIFIER:exon6/7:c.1108-32C>T::,ARSA:ENST00000356098:intron_variant:MODIFIER:exon7/8:c.1108-32C>T::,ARSA:ENST00000395619:intron_variant:MODIFIER:exon7/8:c.1108-32C>T::,ARSA:ENST00000395621:intron_variant:MODIFIER:exon7/8:c.1108-32C>T::,ARSA:ENST00000453344:intron_variant:MODIFIER:exon6/7:c.850-32C>T::,ARSA:ENST00000547307:intron_variant:MODIFIER:exon6/7:c.1102-32C>T::,ARSA:ENST00000547805:intron_variant:MODIFIER:exon7/8:c.1102-32C>T::		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs762673	0.8007	0.8031	9064,.	0.6552,0.8597,0.9799,0.7784,0.8252	0.1850			0.01,0.13	3.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chr22	51065524	51065524	C	A	het		QUAL=2182;DP=299;AF=0.47;MQM=60	ARSA	intron	ARSA:ENST00000216124:intron_variant:MODIFIER:exon2/7:c.466-44G>T::,ARSA:ENST00000356098:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000395619:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000395621:intron_variant:MODIFIER:exon3/8:c.466-44G>T::,ARSA:ENST00000453344:intron_variant:MODIFIER:exon2/7:c.208-44G>T::,ARSA:ENST00000547307:intron_variant:MODIFIER:exon2/7:c.460-44G>T::,ARSA:ENST00000547805:intron_variant:MODIFIER:exon3/8:c.460-44G>T::	regulatory_region_variant:promoter	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs6151413	0.0086	0.0153	1,.	0.0035,0.0038,0.0075,0.0175,0.0096	-1.5180			0.05,0.14	2.51			loss/acceptor/51065523-51065524/Medium/4.624452			2	272	0 / 20					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chrX	70594925	70594925	-	A	het		QUAL=79;DP=89;AF=0.15;MQM=58	TAF1	intron	TAF1:ENST00000276072:intron_variant:MODIFIER:exon3/37:c.413-76dup::,TAF1:ENST00000373790:intron_variant:MODIFIER:exon3/37:c.413-76dup::,TAF1:ENST00000423759:intron_variant:MODIFIER:exon3/38:c.413-76dup::,TAF1:ENST00000449580:intron_variant:MODIFIER:exon3/38:c.413-76dup::		313650 [GENE=TAF1 PHENOS=Dystonia-Parkinsonism,X-linked,314250,X-linked recessive/Mental retardation,X-linked,syndromic 33,300966,X-linked recessive];			AluSg (SINE/Alu)	rs774753344		0.0162	0,9						0.16						1	22	0 / 0					TAF1 (inh=XLR oe_syn=1.09 oe_mis=0.44 oe_lof=0.00)
chrX	70596517	70596517	A	-	het		QUAL=11;DP=7;AF=0.43;MQM=60	TAF1	intron	TAF1:ENST00000276072:intron_variant:MODIFIER:exon4/37:c.533-271del::,TAF1:ENST00000373790:intron_variant:MODIFIER:exon4/37:c.533-334del::,TAF1:ENST00000423759:intron_variant:MODIFIER:exon4/38:c.533-271del::,TAF1:ENST00000449580:intron_variant:MODIFIER:exon4/38:c.533-334del::		313650 [GENE=TAF1 PHENOS=Dystonia-Parkinsonism,X-linked,314250,X-linked recessive/Mental retardation,X-linked,syndromic 33,300966,X-linked recessive];			AluSx3 (SINE/Alu)	rs1387183780		0.1013	80,268		0.1640				2.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TAF1 (inh=XLR oe_syn=1.09 oe_mis=0.44 oe_lof=0.00)
chrX	73641214	73641214	T	G	het		QUAL=316;DP=194;AF=0.37;MQM=59	SLC16A2	5'UTR	SLC16A2:ENST00000276033:5_prime_UTR_variant:MODIFIER:exon1/6:c.-37T>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];			GA-rich (Low_complexity)	rs1381207380					0.3290			0.31,0.91	16.11			loss/donor/73641213-73641214/Medium/1.108882			2	273	0 / 0					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	73641569	73641569	T	C	het		QUAL=650;DP=359;AF=0.20;MQM=60	SLC16A2	missense	SLC16A2:ENST00000276033:missense_variant:MODERATE:exon1/6:c.319T>C:p.Ser107Pro:,SLC16A2:ENST00000587091:missense_variant:MODERATE:exon1/6:c.97T>C:p.Ser33Pro:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	21462 [benign DISEASE=Allan-Herndon-Dudley syndrome,History of neurodevelopmental disorder,not specified];		(AGCCGG)n (Simple_repeat)	rs6647476	0.6638	0.5405	2129,3968	0.6863,0.3358,0.9587,0.4064,0.6345	-0.3900	T(0.44),T(0.29)	B(0.00),B(0.40)	0.04,0.34	9.53	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	73749319	73749319	T	G	hom		QUAL=9692;DP=300;AF=1.00;MQM=60	SLC16A2	intron	SLC16A2:ENST00000276033:intron_variant:MODIFIER:exon5/5:c.1621+43T>G::,SLC16A2:ENST00000587091:intron_variant:MODIFIER:exon5/5:c.1399+43T>G::		300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	159903 [likely benign DISEASE=not specified];			rs5937843	0.3438	0.6056	3021,4488	0.2084,0.4747,0.0318,0.8099,0.5055	0.3890			0.00,0.08	5.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	73751023	73751023	C	G	hom		QUAL=3913;DP=168;AF=0.99;MQM=60	SLC16A2	intron	SLC16A2:ENST00000276033:intron_variant:MODIFIER:exon5/5:c.1622-145C>G::,SLC16A2:ENST00000587091:intron_variant:MODIFIER:exon5/5:c.1400-145C>G::		300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];				rs5937844		0.5874	3005,4602		0.0520			0.07,0.15	4.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	133609078	133609078	T	-	het		QUAL=71;DP=114;AF=0.18;MQM=60	HPRT1	intron	HPRT1:ENST00000298556:intron_variant:MODIFIER:exon2/8:c.135-121del::		308000 [GENE=HPRT1 PHENOS=HPRT-related gout,300323,X-linked recessive/Lesch-Nyhan syndrome,300322,X-linked recessive];			AluJb (SINE/Alu)	rs1484936568		0.0088	0,2		-0.0730				4.37						0	43	0 / 0					HPRT1 (inh=XLR oe_syn=0.59 oe_mis=0.26 oe_lof=0.00)
chrX	133609110	133609110	G	A	hom		QUAL=4306;DP=197;AF=0.98;MQM=60	HPRT1	intron	HPRT1:ENST00000298556:intron_variant:MODIFIER:exon2/8:c.135-101G>A::		308000 [GENE=HPRT1 PHENOS=HPRT-related gout,300323,X-linked recessive/Lesch-Nyhan syndrome,300322,X-linked recessive];			AluJb (SINE/Alu)	rs117407	1.0000	0.9993	6930,6989		0.2730			0.01,0.13	3.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPRT1 (inh=XLR oe_syn=0.59 oe_mis=0.26 oe_lof=0.00)
